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ABSTRACT OF DISSERTATION

THE IMPACT OF MATERNAL NUTRITION DURING PREGNANCY ON
INFLAMMATION AND BIRTH OUTCOMES
More than 85% of American adults do not consume recommended amounts of
fruits or vegetables. Preterm birth and hypertensive disorders of pregnancy are common
adverse conditions affecting pregnancy and are leading causes of maternal and fetal
morbidity and mortality. Preterm birth affects nearly 10% of all births in the United
States and is on the rise, as are hypertensive disorders, which have increased by 25% over
the last two decades. Pregnancy is a state of controlled inflammation, and dysregulation
has been linked to preterm birth and other adverse gestational outcomes. A healthy diet is
recommended in pregnancy, but little is known about the effect fruit and vegetable intake
on perinatal outcomes. Omega-3 (n-3) fatty acids are essential dietary components and
are known to affect inflammatory state, but little is known about how they affect
inflammation in pregnancy. As current evidence is lacking, further research is needed to
investigate the relationships between maternal nutrition in pregnancy, inflammation and
birth outcomes.
The purposes of this dissertation were to: 1) to review and evaluate the current
evidence on the relationship between n-3 fatty acids and inflammation in pregnancy; 2) to
evaluate the current state of the science on the impact of maternal dietary consumption of
fruits and vegetables on preterm birth, gestational diabetes, preeclampsia, small for
gestational age, gestational weight gain and measures of inflammation or oxidative stress
in pregnancy; and 3) to examine relationships between maternal dietary intake of fruits
and vegetables, cytokine expression in early and mid-pregnancy, preterm birth and
gestational hypertension.
A critical review of literature examining the relationship between inflammation
and n-3 intake during pregnancy found that multiple inflammatory cytokines in maternal
and fetal tissues were lower in women who received n-3 supplements. A second review
of literature review supported an inverse relationship between fruit and vegetables and
risk of preeclampsia and suboptimal fetal growth. The available evidence was insufficient
to establish relationships between fruit and vegetable intake and gestational diabetes,
preterm birth or inflammation. A study evaluating the relationships between maternal
fruit and vegetable intake, inflammation and birth outcomes was conducted. This study

provided evidence supporting a relationship between first and second trimester cytokine
expression and maternal dietary intake of fruits and vegetables. Those who met
recommended vegetable intake in the first trimester had higher first trimester serum CRP,
IL1-α, IL-6 and TNF-α and lower first trimester cervicovaginal IL-6 levels. Those who
met recommendations for first trimester fruit intake had 56% lower risk for preterm birth.
Those who met second trimester vegetable intake recommendations had more than twice
the risk of developing gestational hypertension.
The results of this dissertation provide support for the beneficial effects of omega3 fatty acids and fruit and vegetable intake in pregnancy. Maternal intake of these dietary
components may promote optimal immune status during pregnancy. Supplementation of
maternal omega-3 fatty acids may help regulate inflammation via the anti-inflammatory
effects their bioactive eicosanoids exert. Fruit and vegetables have antioxidant and antiinflammatory effects that may also help balance the inflammatory state during pregnancy.
These dietary components may help promote favorable immune status during pregnancy
and reduce risk of adverse perinatal outcomes such as poor fetal growth, hypertensive
disorders of pregnancy and preterm birth.
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CHAPTER ONE: Introduction
The purpose of this dissertation was to examine relationships between maternal
nutrition during pregnancy, maternal inflammatory state during pregnancy and adverse
perinatal outcomes. Women are advised to eat a healthy diet during pregnancy. This
healthy diet should include a variety of foods to meet the nutritional needs of both the
mother and growing fetus. Pregnancy is a state of controlled inflammation, and alterations
to this inflammatory state may contribute to poor outcomes including preterm birth,
hypertension and poor fetal growth. The purpose was addressed in three manuscripts that
comprise Chapters Two through Four. Chapter 2 is a review and evaluation of the current
evidence on the relationship between maternal omega-3 fatty acid intake and inflammation
in pregnancy. Chapter 3 is a report on the state of the science on the impact of maternal
dietary consumption of fruits and vegetables on the incidence of preterm birth, gestational
diabetes, preeclampsia, small for gestational age, gestational weight gain and measures of
inflammation or oxidative stress in pregnancy. Chapter Four is a study of the relationships
among maternal intake of fruits and vegetables, trimester specific cytokine expression in
early and mid-pregnancy and birth outcomes. Chapter Five is a synthesis of the chapters
with implications for future research and clinical practice integration.
Most Americans do not meet recommend intake for fruits, vegetables or dairy and
exceed those for added sugar, saturated fats and sodium ("Facts & Statistics," 2017). Poor
diet quality has been linked to increased risk of some cancers, cardiovascular disease, type
2 diabetes and stroke, while healthier dietary patterns may reduce risk of diseases (Casas,
Sacanella, & Estruch, 2014; Griffiths et al., 2016; Micha et al., 2017).
Inflammation arises from the body’s response to injury and is the primary
mechanism of signaling the body to defend and repair damaged tissues. Dysregulation in
1

inflammatory cascade may be responsible for development of chronic diseases such as
cancer, cardiovascular disease and type 2 diabetes as well as inflammatory diseases such
as rheumatoid arthritis and inflammatory bowel disease (Hunter, 2012; Kollias, Douni,
Kassiotis, & Kontoyiannis, 1999; H. Li et al., 2017; Subirana et al., 2018). Diet related
inflammation is one possible mechanism underlying the diet-disease connection.
Dysregulation of the tightly controlled inflammatory state during pregnancy has
been implicated in adverse gestational outcomes. Preterm birth, or delivery prior to 37
weeks of gestation, is one adverse outcome that may be related to a dysregulated
inflammatory state. Nearly 10% of births in the United States occur preterm (H. B. Martin
JA, Osterman MJK, Driscoll AK, Drake P. , 2018) and are a leading cause of infant
morbidity and mortality (CDC, 2017b). Hypertensive disorders of pregnancy represent a
group of disorders unique to pregnancy. Gestational hypertension is high blood pressure
alone after 20 weeks gestation, while diagnosis of preeclampsia requires signs of other
organ involvement. Hypertensive disorders are a leading cause of both maternal and infant
morbidity and mortality worldwide (Foundation, 2013). Both preterm birth and
hypertensive disorders are associated with dysregulation of immune function in pregnancy
(Aggarwal et al., 2019; Brou et al., 2012; Cappelletti, Della Bella, Ferrazzi, Mavilio, &
Divanovic, 2016; U. N. Das, 2006). Consequently, improved immune function regulation
may promote healthier gestational outcomes.
Result from several studies support a link between nutrition and adverse gestational
outcomes. Healthy dietary patterns rich in fruits and vegetables, whole grains, unprocessed
meats and fish may reduce the risk of hypertensive disorders of pregnancy and preterm
birth (Haugen et al., 2008; Mikkelsen et al., 2008; Raghavan et al., 2019; Schoenaker,
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Soedamah-Muthu, Callaway, & Mishra, 2015), but little is known about how individual
foods or food groups affect birth outcomes. Thus, the purpose of this dissertation was to
examine the impact of dietary intake of fruits, vegetables and omega-3 fatty acids on
maternal inflammation and birth outcomes.
Theoretical framework
The framework described by Ma (2013) guided this dissertation (Figure 1.1). The
framework includes all the key concepts of this dissertation and provided a theoretical basis
on which to explore the relationships among maternal nutrition, inflammation, and birth
outcomes. This dissertation was focused on the influence of nutrition on biomarkers of
stress and birth outcomes in the context of sociodemographic variables and health
behaviors. Thus, the scope of this dissertation did not include the relationships of food
environment or neighborhood characteristics.
According to the model, demographic variables including income or
socioeconomic status, marital status, maternal age, and race or ethnicity affect health
behaviors and may influence biological factors. Health behaviors include maternal dietary
intake, exercise and physical activity level, and smoking status. They are potential
mediators of the relationships between sociodemographic variables and maternal risk
factors with birth outcomes. Maternal risk factors include stress, prior birth history,
maternal weight and body mass index, gestational weight gain and infection, which
influence both biological factors and birth outcomes. Biological factors may be affected by
maternal factors and nutrition. Nutritional factors may mediate the effects of
sociodemographic characteristics, health behaviors and maternal risk factors and affect
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biological factors. Combined these relationships demonstrate how nutrition interventions
could promote more positive birth outcomes.
Figure 1.1 Framework of food environment and birth outcomes (Ma, 2013)

Chapter summaries
Chapter Two is a systematic review that aims to fill an existing gap in the
understanding of the effect of omega-3 fatty acids on inflammatory markers in pregnancy.
Dysregulation of maternal inflammatory status during pregnancy has been linked with
increased risk for preterm birth (Moghaddam Banaem, Mohamadi, Asghari Jaafarabadi, &
Aliyan Moghadam, 2012; Ruiz et al., 2012), gestational diabetes and hypertensive
disorders of pregnancy (U. N. Das, 2006; Harmon et al., 2016; Yu et al., 2017).
Supplementation of omega-3 fatty acids has been shown to regulate inflammation (Wu &
Schauss, 2012). Omega-3 fatty acids were supplemented in the maternal diet via salmon or
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capsule preparation in the seven studies were included in the review. Biomarkers of
inflammation were measured in maternal serum and adipose tissue as well as fetal cord
blood and placental tissues. This review summarizes and evaluates the current evidence on
the relationship between omega-3 fatty acid consumption and markers of inflammation in
pregnancy.
Chapter Three is a review of the literature that evaluated and summarized evidence
to address gaps that exist in relationship between fruit and vegetable intake, adverse
gestational outcomes and inflammation/oxidative stress in pregnancy. Adverse pregnancy
outcomes, including preeclampsia, preterm birth, gestational diabetes and infant growth
restriction, are associated with dysregulation of inflammation and oxidative stress. Fruit
and vegetable intake are also known to affect inflammation and oxidative stress and
improve outcomes in other chronic diseases with proinflammatory pathologies. The review
aimed to improve the understanding of the influence of dietary fruit and vegetable intake
on perinatal outcomes and markers of inflammation and oxidative stress. Nineteen articles
met inclusion criteria with fruit and/or vegetable intake as an independent variable and at
least one of the outcomes of interest: preeclampsia, preterm birth, gestational diabetes, fetal
growth, gestational weight gain or inflammation/oxidative stress.
Chapter Four is a secondary analysis of data. This study was conducted expand on
the limited available evidence examining relationships between maternal dietary intake of
fruits and vegetables during early and mid-pregnancy on preterm birth, gestational
hypertension. In addition is the first to measure the impact of fruit and vegetable intake on
trimester specific markers of inflammation in pregnancy. The sample consisted of 181
pregnant women 18 years or older with healthy singleton gestation. Those with complete
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dietary intake, cytokine values and birth outcome data. The mean age of the women was
27.0 years (SD=5.4). More than half had less than $50,000 per year household income
(52.8%), most had at least a high school education (90.6%), and were white (81.7%). The
majority were non-smokers (79.4%), were married or cohabitating (81.1%) and were first
time mothers (64.1%). More than half were overweight or obese prior to pregnancy
(52.9%). Linear regression was used to address Aim 1, which was to determine whether
meeting recommendations for fruit or vegetable intake in the first or second trimester
predicted serum and cervicovaginal cytokine expression while controlling for factors
affecting inflammation such as smoking. Aim 2 was addressed by a logistic regression to
determine if fruit or vegetable intake predicted either preterm birth or gestational
hypertension while controlling for common risk factors.
Chapter Five is a brief summary and synthesis of Chapters, 2, 3, and 4. The
integration of the findings was used to develop recommendations for evidence-based
clinical practice changes and to make recommendations for future research.

Copyright © Lori Ellen Ogden 2019
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CHAPTER TWO: Systematic review of ability of omega 3 fatty acids role in
suppressing inflammation in pregnant women
Introduction/Background
Adverse perinatal outcomes account for a small proportion of all births statistically,
and a large proportion of healthcare expenditures. Conditions such as preterm birth (PTB),
preeclampsia, gestational hypertension (GHTN), and gestational diabetes (GDM) result in
increased maternal healthcare costs during pregnancy, at birth, and often for the newborn
infant.
Premature birth occurs at <37 completed weeks gestation and is the focus of the
March of Dimes, one of the leading sources of research and funding on prematurity (2016).
The rate of preterm birth has increased for last three years following a seven year decline
and totaled nearly 10% of all births (J. A. Martin, Hamilton, Osterman, Driscoll, & Drake,
2018) . Premature birth and its sequelae are the largest contributors to infant death, and
account for 36% of the more than 23,000 infant deaths occurring in 2013 (Dimes, 2016).
The most recent estimate in 2005 of the economic burden of prematurity totaled more than
$26.2 billion ("Preterm Birth: Causes, Consequences, and Prevention," 2006).
Hypertensive disorders of pregnancy include preeclampsia/eclampsia, and GHTN.
Preeclampsia is a multisystem disorder of human pregnancy of unknown causes. Maternal
systemic manifestations include hypertension, proteinuria or other organ involvement,
while fetal abnormalities include growth restriction, low amniotic fluid and abnormal
oxygenation and placental blood flow (B. Sibai, G. Dekker, & M. Kupferminc, 2005).
Preeclampsia becomes eclampsia with the onset of maternal seizures. Gestational
hypertension is elevated blood pressure that starts after 20 weeks gestation without signs
of other organ involvement. Preeclampsia is closely associated with PTB, with one recent
7

analysis reporting a gestational age at delivery of approximately two weeks less for those
with preeclampsia than those without (Stevens et al., 2017). They also report total maternal
and fetal costs for those affected by preeclampsia in the United States of $2.18 billion over
the usual costs of pregnancy and birth.
Altered glucose metabolism in pregnancy can result from pre-gestational diabetes
(type 1 or 2) or arise during pregnancy (GDM). Known risks of GDM are older maternal
age, obese/overweight, and non-white race. The prevalence of GDM is estimated to be as
high as 9.2% in the United States in 2010, with prevalence at least one in 20 pregnancies
affected (DeSisto, Kim, & Sharma, 2014). The estimated cost of GDM in 2007 was an
additional $3,305 per pregnancy, or an increase in medical costs for maternal care during
pregnancy, birth and postpartum of $506 million, and newborn costs of $40 million in the
United States (Chen et al., 2009)
Inflammation and Pregnancy
The immune system is focused on recognition of antigens found on the surface of
bacteria, viruses or fungi and mounting a cellular response to eliminate them and repair the
damage caused. Inflammatory substances are released from damaged cells to promote
swelling and isolate the damaged tissue, as well as recruit cells to remove the damaged
tissue. Due to the constant death/damage and repair/replacement of body cells, the
inflammatory response is dynamic and requires balance between pro- and antiinflammatory regulators. Dysregulation of the immune or inflammatory response can lead
to over or under reaction as well as destruction of the body’s own tissues.
During gestation the body must work to protect the “foreign” fetus from attack by
these systems in order to maintain a healthy pregnancy by tightly regulating the balance
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between both pro- and anti-inflammatory states during this time of controlled inflammation
(Bowen, Chamley, Mitchell, & Keelan, 2002; Calder, 2010). Key cellular components of
immune function are types of white blood cells called T helper cells (Th) and their
precursors T lymphocytes. T helper cells produce signaling molecules called cytokines
direct the inflammatory response. Type 1 Th are important in intracellular response to
microbial invasion and promote the immune response. These cells produce interferon
gamma (IFN-γ), tumor necrosis factor alpha (TNFα), and Interleukin (IL) 2. Type 2 Th
cells function in extracellular immunity are more anti-inflammatory. They produce IL 4,
IL-5, IL-6, IL-10, and IL-13. Type 2 immunity predominates during successful human
pregnancy (Bowen, Chamley, Keelan, & Mitchell, 2002).
As in times of illness and disease, alterations in immune response may lead to
adverse outcomes in pregnancy. Researchers recently examined the relationship between
dysregulation of inflammation and pregnancy complications. Maternal serum C reactive
protein (CRP) levels above four in the first half of pregnancy resulted in nearly nine times
greater risk for preterm birth (Moghaddam Banaem et al., 2012) while elevated IL-1Ra in
the second trimester resulted in 2.5 greater odds of preterm birth (Ruiz et al., 2012). Lower
levels of anti-inflammatory IL-10 and or transforming growth factor-beta (TGF-β), have
been reported in those who delivered preterm (Pereira et al., 2016). Recent data also
supports a relationship between alterations in inflammatory cytokines with preeclampsia
and gestational diabetes (U. N. Das, 2006; Harmon et al., 2016; Yu et al., 2017).
Omega3 Fatty Acids and Inflammation
Polyunsaturated fatty acids (PUFA) are one of four types of dietary fats. Alpha
linolenic acid (ALA) and linoleic acid (LA) are n-3 and n-6 fats respectively, termed
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“essential fatty acids” in the diet as they cannot be synthesized in the body from their
precursor oleic acid (OA). Both n-6 and n-3 fats provide energy in the diet and are an
essential component of the phospholipid cell membrane. Humans can synthesize saturated
fatty acids and monounsaturated fatty acids through desaturation and elongation reactions.
However, humans lack the necessary desaturase enzyme necessary for synthesizing n-3
and n-6, thus intake of n-3 ALA and n-6 LA is essential. Plant sources provide only ALA,
while marine sources provide EPA and DHA. The long chain n-3 PUFA eicosapentaenoic
acid (EPA) is synthesized from ALA. Further synthesis of EPA results in the n-3 long chain
PUFA docosahexaenoic acid (DHA) (Jane Higdon, 2019).
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Figure 2.1 General overview of synthesis and actions of lipid mediators produced from
arachidonic acid, EPA and DHA. COX, cyclooxygenase; LOX, lipoxygenase; LT,
leukotriene; PG, prostaglandin

from Calder, P. C. (2010). Omega-3 fatty acids and inflammatory processes.
Nutrients, 2(3), 355-374. doi:10.3390/nu2030355

These long chain PUFA promote fluidity in the cell membrane, regulate gene
expression and inflammation. As components of cell membranes, they can interfere with
receptors in the membrane and block or promote gene transcription directly. Omega-3 are
given preference over n-6 for incorporation into cell membranes. In other cases, n-3
regulate the amount of transcription factors in the cell nucleus. These transcription factors
are responsible for production of eicosanoids and cytokines (Jane Higdon, 2019).
In addition to cell membrane structure, long chain PUFA are involved in other
biological functions. Chemical messengers called oxylipins are derived from PUFA. The
most common oxylipins are eicosanoids. Eicosanoid production is stimulated when
hormones and cytokines signal release of substrate PUFA from cell membranes. The series
2 prostanoids, thromboxanes, and series four leukotrienes arising from n-6’s are primarily
pro- inflammatory. In opposition, the series 3 prostanoids, leukotrienes and neuroprotectins
that arise from n-3 are less inflammatory than the n-6. Some eicosanoids derived from
EPA antagonize those produced by AA promoting more anti-inflammatory state (Calder,
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2010). Other cell signaling substances that arise from n-3 PUFA are specialized proresolving mediators and include their precursors the resolvins, protectins and maresins.
They are potent anti-inflammatory and immune resolving molecules (Figure 2.1).
The typical “western” diet includes large amounts of foods containing vegetable
oils (corn oil, soybean oil, safflower oil), which are high in LA. Plants are also the source
of ALA but LA tends to predominate. Plants high in ALA are less commonly consumed
(chia seeds, hemp seed, walnut and flax). The “Western” diet contains higher n-6 and lower
n-3 amounts, with a ratio of 10-25:1, with optimal ratios of 1-4:1 (Simopoulos, 2000).
Improved ratios of n-2:n-6 PUFA can be altered by either decreasing the intake of n-6 fats
and/or increasing the intake of n-3. Currently, the American Congress of Obstetricians and
Gynecologists’ dietary guidelines for pregnant women do not include n-3 (2015). Fish
intake is limited to 8-12 ounces per week; however, certain fish are excluded or limited
due to concerns about contamination with mercury. This may contribute to worsening of
the relative deficiency of n-3 in the Western diet for pregnant women.
Supplementing n-3 during pregnancy may affect inflammatory state by several
mechanisms. First, the increased intake improves n-6:n-3 ratios. Improved n-3 intake
allows more availability for incorporation into cell membranes as well as production of
eicosanoids. This may result a more anti-inflammatory balance in eicosanoids via increased
production of inflammation reducing resolvins and protectins and lower excretion of labor
initiating PGE2. Omega-3 fatty acids have been also been shown to affect production of
inflammatory proteins such as cytokines through production of transcription factors
involved in cell signaling (Calder, 2010) (Figure 2.2). Therefore, the purpose of this paper
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was to evaluate the current evidence for the relationship between maternal intake of omega3 fatty acids and inflammation in pregnancy.
Figure 2.2 Pathways for omega-3 to impact placental oxidative stress and inflammation

from Leghi, G. E., & Muhlhausler, B. S. (2016). The effect of n-3 LCPUFA
supplementation on oxidative stress and inflammation in the placenta and maternal
plasma during pregnancy. Prostaglandins Leukot Essent Fatty Acids, 113, 33-39.
doi:10.1016/j.plefa.2016.08.010

Methods
Electronic searches were conducted using PubMed and CINAHL. Search terms
were used in combination: pregnan* OR prenat*, omega-3 OR PUFA, and inflammat* OR
infect* OR cytokin*. Original research articles in English were included if published within
the last 10 years for most relevant and up to date sources. Title review of 155 articles
excluded those not performed in humans or those where the pregnant woman and/or fetus
were not the primary outcome of interest, as were duplications. Only those including
maternal intake of n-3 fatty acids as the dependent variable were included, as cell cultures
using exposure to fatty acids in the laboratory setting are not be representative of human
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physiology and should be cautiously interpreted. Abstract and full text review screened for
those meeting all inclusion criteria and seven articles were included in the full review
(Figure 2.3).
All articles were assessed for quality and assigned scores. The method used to
evaluate the quality of randomized controlled trials for brain cancer and includes items
that, when omitted, result in increased bias (Lai R, 2006). The evaluation includes 15 key
items from the Consolidated Standards of Reporting Trials recommended for use in all
randomized controlled trials. The range of possible scores is zero-15, with the included
studies scores ranging from nine to 15, and mean of 11.7. A matrix table was developed to
organize the most relevant data on the relationship between n-3 intake and inflammation
in pregnancy. The headings used were author and year, sample participants and setting,
sources of inflammatory measures, type of intervention (supplement) used, and key
findings, with a separate column for scores (Table 2.1).
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Figure 2.3 Literature flow diagram
Number of articles retrieved =267

Number of articles after remove duplicates and
apply inclusion criteria=196

Number of articles for title review=155

Number of articles for full text review=36

Number excluded
based on title
review=119

Exclusion criteria
applied for full
text review:
•
•

Number of articles included in final review =7
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•

Only
humans
Omega- as
dependent
variable
Pregnant
women =/or
fetus as
population
of interest

Results
Sample Characteristics/Interventions
The studies were randomized controlled trials published between 2008 and 2016
and enrolled between 40 and 343 pregnant women (Garcia-Rodriguez et al., 2017; Maricela
Haghiac et al., 2015; Harper et al., 2013; Jamilian et al., 2016; Keelan et al., 2015; KraussEtschmann et al., 2008; Warstedt, Furuhjelm, Duchen, Falth-Magnusson, & Fageras,
2009). Two studies were conducted in the United States (M. Haghiac et al., 2015; Harper
et al., 2013). One each in the United Kingdom (Garcia-Rodriguez et al., 2012), Australia
(Keelan et al., 2015), Sweden (Warstedt et al., 2009), and Iran (Jamilian et al., 2016). One
study included subjects from Spain, Hungary and Germany (Krauss-Etschmann et al.,
2008). All studies sought to examine the association between intake of n-3 and markers of
inflammation/immunity in pregnant women both with and without specific conditions
(such as GDM, obesity, allergies, or PTB). The studies used salmon (Garcia-Rodriguez et
al., 2012), oral capsules (M. Haghiac et al., 2015; Harper et al., 2013; Jamilian et al., 2016;
Keelan et al., 2015; Warstedt et al., 2009) or a milk-based supplement (Krauss-Etschmann
et al., 2008) to provide the omega-3 or placebo to participants. Fish diet history was also
assessed at enrollment in one instance to provide a measure of dietary n-3 intake prior to
treatment (Harper et al., 2013). The dosages of EPA ranged from 163mg to 1,500mg per
day, while DHA ranged from 331mg to 3,700mg per day. Gestational age at treatment
initiation ranged from 10 to 25 weeks gestation at onset for the included studies, with all
except M. Haghiac et al. (2015) starting in the second trimester. Only overweight or obese
participants were enrolled in one study (M. Haghiac et al., 2015); two included women
with allergies (Keelan et al., 2015; Warstedt et al., 2009), and one only included women
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with gestational diabetes (Jamilian et al., 2016). All these maternal states may affect or
alter the inflammatory response in addition to pregnancy. Other inclusion criteria for the
pregnant women were to have otherwise healthy singleton pregnancies (i.e. non-smokers,
no pre-existing diabetes, hypertension, or other significant health problems) and did not
previously take fish oil or n-3 supplements.
Measures/Outcomes Used in Included Studies
Inflammatory biomarkers. The most common pro-inflammatory biomarkers
measured were IL-6, TNF-α, IL-1, IL1-β, IL-8, and C reactive protein (CRP). Common
anti-inflammatory biomarkers measured were: IL-10, and IL-4. Other measures used to
assess inflammatory status were prostaglandin E2 (PGE2), which is an eicosanoid generated
from AA, as well as those initiating, mediating, or suppressing the immune response
(specialized pro resolving mediators [SPM]). Serum cytokine concentrations and cytokine
gene expression were used to measure inflammation. Maternal blood was used for cytokine
analysis in all included studies (Garcia-Rodriguez et al., 2012; M. Haghiac et al., 2015;
Harper et al., 2013; Jamilian et al., 2016; Keelan et al., 2015; Krauss-Etschmann et al.,
2008; Warstedt et al., 2009). Cord blood was utilized for inflammatory biomarker analysis
once (Keelan et al., 2015), while placental tissue was used in three studies (M. Haghiac et
al., 2015; Keelan et al., 2015; Melody et al., 2015). One study also included maternal
adipose tissue for evaluation (M. Haghiac et al., 2015).
Impact of fatty acid intervention on inflammation. The researchers used change
over time in the same participants or differences between groups (supplement vs placebo)
to evaluate trends in cytokine expression and the effect of the intervention on the individual
biomarkers. Investigators in three studies reported utilizing regression analysis to assess
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the relationship between treatment group and inflammatory markers (Garcia-Rodriguez et
al., 2012; Harper et al., 2013; Keelan et al., 2015).
Findings and Data Analysis of Included Studies
Maricela Haghiac et al. (2015) reported maternal serum CRP levels decreased over
time for those who received n-3 (-3.2 ±5.2µg/ml) and increased for those who did not (+.82
±6.9 µg/ml, p<.05); as did Jamilian et al. (2016) (-3375.7 ±4863.8 ng/ml vs
82.8±3149.7ng/ml, p.001). Lower geometric means of maternal IL-1 and TNF-α levels
were reported at delivery in those who received treatment (.69 vs .80, p<.00; .054±.03 vs
.65±.05, p<.00) by Krauss-Etschmann et al. (2008). Jamilian et al. (2016) reported
downregulated gene expression of IL-1 and TNF-α in those who were supplemented as
well (p=.007 and p=.001). Maternal adipose cells had significantly lower gene expression
of IL-6, IL-8, and TNF-α mRNA in those women given n-3 supplementation during
pregnancy (<.001) (Maricela Haghiac et al., 2015).
Cord blood and placental cytokine levels also differed for those who received
treatment with n-3. Krauss-Etschmann et al. (2008) reported lower cord levels of IL-4 (.54
vs .64, p<.00) and IL-13 (.61 vs .85, p<.00) and IL-1 (.81vs .85, p<.00) for those who
received fish oil supplement compared to those who did not. Placental trophoblast cells
expressed lower levels of IL-6, IL-8 and TNF-α in those in the treatment group than those
who were not (Maricela Haghiac et al., 2015).
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Table 2.1 Characteristics of included studies on omega-3 intake and inflammation
Author (Date); Sample/Setting
Participants
Garcia-Rodriguez, et
al. (2012).

Measures

Intervention

Key Findings

Consort

Maternal blood samples were
collected at baseline (20weeks) and
at 34 and 38 weeks for fatty acid
analysis and biomarker analysis.

Tx: 2 portions/week of farmed No differences in plasma
salmon containing a total of
biomarkers based on treatment
1.14g EPA and 2.32g DHA,
received.
28mcg vitamin D, and 86 mcg
selenium, from 20 weeks
gestation through delivery.
Control: continue usual diet

9

Haghiac, et al. (2015). N=72
overweight/obese
pregnant women
United States

-Visit 1(8-16 weeks) and visit 2
(34-36 weeks): height/weight,
maternal blood sample (glucose,
insulin, fatty acid, and cytokines).
-Placental tissue, cord blood at
delivery.
-Maternal adipose tissue was
collected from subset (n=16)
women with singleton pregnancy at
term undergoing an elective
cesarean section for isolation of
adipose cells.

Tx: 2 capsules 2 x/day
containing 800mg DHA and
1200mg EPA (total 2,000mg
PUFA).
Control: matching placebo
capsules.
Given from week 10-16 until
delivery.

Lower maternal CRP expression
in treatment group than control
group and decreased significantly
over time; control group levels
increased. Treatment group had
lower IL-6, IL-8, TNFα, TLR4 in
adipose and placental tissue.

15

Harper, et al. (2013).

Maternal blood samples were
collected between 16-22 weeks
gestation before starting treatment,
and again between 25-28 weeks for
cytokine analysis in women with a
history of prior preterm birth.

All participants received
weekly injections 17 OHPC
(250mg).
Tx: daily supplement of
2,000mg omega-3 PUFAs.
Control: matching placebo
capsules.
Treatment initiated at
enrollment (16-22 weeks).

No differences in cytokine
expression based on
supplementation.

11
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N=123
United Kingdom

N=343
United States

Table 2.1 (continued) Characteristics of included studies on omega-3 intake and inflammation
Author (Date); Sample/Setting
Measures
Intervention
Participants
Krauss-Etschmann,
S., et al. 2008).

N=197 pregnant
women.
Spain, Hungary,
Germany

Keelan, et al. (2015). N=51 allergic
pregnant women
Australia

Key Findings
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Maternal blood collected at study
entry, 30 weeks and at delivery.
Cord blood was also collected
delivery for phospholipid and
cytokine analysis.

Treatment:
Milk based supplement
containing vitamins and
minerals plus either fish oil
(0.5g DHA and 0.15 g EPA),
MTHF (400 mcg 5-MTHF), or
both.
Control: Milk based
supplement.
Treatment given from 22
weeks gestation until delivery.

Maternal food frequency
questionnaire completed at 20- and
30-weeks gestation. Maternal blood
samples were collected at 36
weeks, cord blood was collected at
birth, and placental tissue was
obtained within 5-10 minutes of
delivery.

Tx: 4 capsules/day containing Specialized pro-resolving
3.7g n-3 PUFA (2.07g DHA, mediator precursors in placenta
1.02g EPA).
increased in those supplemented.
Control group: 4 capsules olive
oil/day. Treatment from 20
weeks until delivery.

11

Tx: 1000mg fish oil capsules Maternal expression of CRP,
(180mg EPA, 120mg DHA)
TNFα, and IL-1 were lower after
twice daily for 6 weeks. (mean treatment compared to placebo.
gestational age at onset 25.3
weeks for placebo, 25.4 weeks
for treatment, p=.89).
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Jamilian, M., Samimi, N=40 with
Maternal blood samples collected
M., Kolahdooz, F.,
gestational diabetes. at enrollment and 6-weeks after
Iran
Khalaji, F., Razavi,
treatment.
M., & Asemi, Z.
(2016).

1. Lower maternal expression of
IFN-γ, IL-1, CRTH2 and CCR4
and higher TGFB levels at
delivery for those who received
fish oil.
2. Lower cord blood expression of
CCR4, IL-13, IL-4, CXCR3 and
IL-1 and higher TGF-β with
omega 3 supplement.

Consort
11

Table 2.1 (continued) Characteristics of included studies on omega-3 intake and inflammation
Author (Date); Sample/Setting
Participants
Warstedt, et al.
(2009).

N=99
Sweden

Measures
At enrollment a 3-day food diary
and maternal blood sample.
Medical data obtained from
medical record. Maternal adipose
tissue was collected if cesarean
section. Maternal blood samples
obtained again within one week of
delivery.

Intervention
Tx: 9 capsules/ day (1.6g EPA,
1.1g DHA) and 23mg αtocopherol.
Control: 9 soybean oil capsules
containing.
From 25 weeks gestation
continued through pregnancy.

Key Findings
Maternal PMBC expression of
PGE2 secretion decreased over
time for those supplemented;
increased for placebo group.

Consort
10

Legend: Tx-treatment; EPA- eicosapentaenoic acid; DHA- docosahexaenoic acid; g-grams; mg-milligrams; mcg-micrograms; PUFA-polyunsaturated fatty acid; PMBC-; MTHFmethyl –tetra-hydrofolic acid; IL-Interleukin; TNF-α-tumor necrosis factor alpha; TLR4-toll like receptor 4; 17 OHPC-17- hydroxyprogesterone caproate; CCR4-chemokine
receptor 4; CXCR3-chemokine receptor 3; TGF-β-transforming growth factor beta; CRP-c reactive protein; IFN-γ-Interferon gamma; CRTH2- chemoattractant receptor-

homologous molecule expressed on Th2 cells.
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Strengths of the review
This systematic review has several strengths. Randomized controlled trials were the
only type of study included, which is the most rigorous research design. The combined
evidence provides a higher level of evidence than the individual research studies.
Weaknesses also exist as this review is only as strong as the rigor of the individual studies.
As discussed previously, there are issues with the ability to interpret the quality and
methodology used by the researchers. Wide variation among the studies existed for timing
of treatment initiation, dosages of n-3, and the vehicle used to administer it which impact
the ability to both interpret and generalize findings. In addition, publication bias cannot be
excluded or evaluated, as it is not possible to know if preference was given to specific
authors or institutions. One final limitation for this review is the limited amount of
published results available for inclusion with only seven trials available.
Weaknesses of evidence
Sources of bias cannot be eliminated in any research study. The authors did not
thoroughly describe the study protocol, including sampling technique, randomization,
study site, or qualifications of those involved in the research which limits the ability to
fully evaluate whether other sources of bias may exist. Sampling bias could have affected
the results of the studies with most using voluntary recruitment and relatively small
samples. The largest sample size was 343, the smallest only 4. Pregnant women are
considered vulnerable and subject to more rigorous protection measures than adults in
general which makes study design and recruitment more challenging. These are relatively
small samples for randomized trials and only two conducted power analyses to justify size
and ensure confidence in the findings (Jamilian et al., 2016; Warstedt et al., 2009).
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Voluntary recruitment was the default for all included studies and may have resulted in
sampling bias. Random assignment was not always blinded to both participants and
researchers, with limited descriptions often not detailed enough to evaluate the reliability
of this crucial process. Minority inclusion was not given priority in any included studies.
Minorities, specifically African Americans, are disproportionately affected by prematurity,
which could affect results obtained as well ("Preterm Birth: Causes, Consequences, and
Prevention," 2006).
Other factors may have influenced findings such as compliance and study variables.
Compliance with the intervention could have also affected results as pregnant women may
have difficulty with taking the supplement due to gastrointestinal issues common to
pregnancy and was one of the main sources of dropout reported among included studies.
Not all investigators measured the impact of supplementation on maternal fatty acid status,
and only one study measured maternal dietary intake prior to treatment. One study included
obese/overweight women, one included only those having/at risk for atopy and one only
included those with GDM, which are conditions that can also affect immune function and
impact maternal inflammatory state and response to n-3. These studies did not compare
affected women to normal controls in order to evaluate group differences based on
supplementation. This would allow broader understanding of which circumstances n-3
supplementation affects disease related inflammation in pregnancy as well.
The lack of theoretical framework included to guide study design and interpretation
is a weakness to for all included studies. Inclusion of a framework would have guided
timing of interventions and cytokine measures. Only three of seven studies reported
reliability and validity measures for the biochemical analyses such as coefficient of
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variances (Maricela Haghiac et al., 2015; Jamilian et al., 2016; Warstedt et al., 2009). This
limits the ability to determine the precision of the laboratory performance and consistency
of the findings for the phospholipid and cytokine analyses that are key to these studies.
Summary of Research
The evidence provided by most studies supported a decrease in inflammation in
response to n-3 fatty acids supplementation. The research in five of seven studies supported
differences between immune biomarkers based on treatment status exist (M. Haghiac et al.,
2015; Jamilian et al., 2016; Keelan et al., 2015; Krauss-Etschmann et al., 2008; Warstedt
et al., 2009) and two did not (Garcia-Rodriguez et al., 2012; Harper et al., 2013).
Maternal levels of some proinflammatory cytokines were different between those
who received supplements containing n-3 than those who did not. Levels of
proinflammatory CRP were significantly lower in women who received n-3 than those who
did not (M. Haghiac et al., 2015; Jamilian et al., 2016). Levels of CRP also decreased over
time in the treatment group, and increased from mid to late pregnancy for those who
received placebo (Maricela Haghiac et al., 2015). Maternal levels of inflammatory TNFα
and IL-1 were also lower for those supplemented, as was interferon (IFN)-γ (Jamilian et
al., 2016; Krauss-Etschmann et al., 2008). Maternal adipose tissue also had lower levels of
inflammatory cytokines IL-6, IL-8, and TNF-α for those women in the treatment group
than those in the control group (Maricela Haghiac et al., 2015)
Fetal levels of some pro-inflammatory cytokines were lower for those who received
supplementation than those who did not. Cord blood IL-1 was lower in those supplemented
(Krauss-Etschmann et al., 2008). Placental cytokine expression of IL-8 and IL-6 was also
lower for the treatment group than the control group (Maricela Haghiac et al., 2015).

24

Findings were conflicting for placental TNF-α, with lower levels reported by M. Haghaic
et al, (2015), and 14 fold higher expression reported by Keelan et al, (2015). However, the
findings from two studies did not support a difference based on fish intake or
supplementation (Garcia-Rodriguez et al., 2012; Harper et al., 2013). Garcia-Rodriguez et
al (2012) provided the supplementation in the form of salmon two times per week and was
the lowest dosage of all included studies. This may account for the lack of differences as
the dosing was too low to affect inflammation. Despite higher dosages in other studies,
there were no significant adverse events reported attributable to the intake of n-3. Harper
et al (2013) provided a daily supplement of n-3, but also administered weekly 17hydroxyprogesterone injections to the women with prior history of PTB. The progesterone
supplement is an approved treatment to reduce the risk of recurrent spontaneous PTB.
Progesterone production in pregnancy promotes Th2 mediated immunity and production
of IL-4 and IL-5, which in turn suppresses Th1 mediated immunity (Piccinni, Scaletti,
Maggi, & Romagnani, 2000). This may not only explain how 17-hydroxyprogesterone
reduces PTB, but why there were no additional differences bases on supplementation with
n-3.
Levels of anti-inflammatory cytokines were either not changed at all, or lower in
those treated. Cord levels of IL-4 and IL-13 were lower in cord blood among mothers in
the treatment group, as were higher placental levels of SPM precursors (Keelan et al.,
2015). The lack of measurable effects of n-3 on pro-inflammatory cytokines was not
unexpected as Graham et al. (2017) reported that anti-inflammatory cytokines did not
change significantly in pregnancy in general.
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Prostaglandin production also affects pregnancy. This eicosanoid arises from n-6
AA and induces both IL-6 and IL-8 production. These cytokines induce cellular changes
in the amniotic membranes that may lead to ruptured membranes and PTB (Bagga, Wang,
Farias-Eisner, Glaspy, & Reddy, 2003; Bowen, Chamley, Keelan, et al., 2002).
Prostaglandin E2 (PGE2) production is enhanced by IL-1, IL-6 and TNF-α, and is a potent
stimulatory of uterine contractions and is a crucial element to the initiation of labor
(Bowen, Chamley, Keelan, et al., 2002). Secretion of PGE2 decreased in the majority of
women supplemented with n-3 (64%), and increased in most of those who did not receive
it (77%, p=.002), despite no significant differences in cytokine expression (Warstedt et al.,
2009). This study only included women with allergies, which is a known altered state of
immune function, which may have unknown effects on maternal immune and
inflammatory status. Another study including only women with allergies only explored
inflammatory factors expressed in placental tissues which prevents comparisons, but the
potential impact of allergic status on PGE2 cannot be eliminated.
Implications
Recent studies confirm the effect of n-3 fatty acid supplementation on some
proinflammatory cytokines in pregnancy. While increasing the amount of n-3 intake in
pregnancy is likely beneficial for pregnant women, there is much that remains unclear.
Further research is needed for clear guidelines and recommendations to emerge. A recent
review by Calder (2015) cited available evidence supporting a dosage between 1.35 and
2.7 g EPA/day as optimal for anti-inflammatory effect in adults. Due to high fetal demands
during gestation, the optimal dosage may be insufficient to meet both maternal and fetal
demand and promote improved n-3:n-6 ratios needed for inflammatory modulation. Both
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DHA and EPA were administered in the included studies, but the effects may differ for
them alone or in differing ratios. Future studies should aim to more clearly define the
optimal dosage of DHA and/or EPA and timing of treatment, and the optimal vehicle to
administer them in.
Maternal blood was the most widely used medium and utilized several different
types of analyses including serum, red blood cell, and gene expression measures. The
operational definition of inflammation included a wide range of biomarkers. Maternal
biomarker patterns during gestation are poorly understood, making comparisons among the
included studies difficult. Greater understanding of inflammation in pregnancy is needed
to establish optimal biomarkers to measure inflammation in pregnancy.
Samples that are more inclusive and representative of the population are needed.
Grouping based on characteristics such as BMI, race, age, or perinatal risks may aid in
determining those who may benefit most. Further research is essential to develop a broader
understanding of inflammation in pregnancy and when or how n-3 supplements may result
in the most beneficial outcomes.
Clinically, there is good reason to recommend inclusion of n-3 supplements for all
pregnant women. The Western diet includes high amounts of n-6 fats and insufficient
amounts of n-3. This is more problematic for pregnant women with the current restrictions
on intake of fish. The included studies did not report any significant adverse effects
attributable to supplementation except for stomach upset.
Conclusions
During the last decade the rate of PTB has changed little and has increased in recent
years. Gestational diabetes and hypertensive disorders of pregnancy, along with preterm
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birth represent significant numbers of affected pregnancies, with significant associated
monetary costs. There are no current recommendations from the American College of
Obstetricians and Gynecologists to include n-3 supplements for women who are pregnant.
A recent Cochrane review supports the ability of n-3 supplement to reduce the risk of PTB,
early PTB (<34 weeks) and low birth weight infants due to high quality evidence. It is time
to align practice with the evidence and recommend all pregnant women receive omega-3
supplements.

Copyright © Lori Ellen Ogden 2019
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CHAPTER THREE: Systematic Review Supports Improved Perinatal Outcomes
with Higher Intake of Fruits and Vegetables
Introduction
Pregnancy and birth outcomes are generally positive in the U.S., but increasing
proportions are affected by adverse maternal or neonatal outcomes. Preeclampsia and
gestational hypertension (GHTN) affects 912.4 per 10,000 pregnancies, and has increased
steadily in recent years (CDC, 2017a). Preterm birth affects nearly 10% of all births in the
U.S. and has risen the last two years following a steady decline since 2007 (H. B. Martin
JA, Osterman MJK, 2017). Gestational diabetes mellitus (GDM) is another adverse
outcome for pregnant women that increases maternal and infant morbidity with prevalence
as high as 9.2% in the U.S. (DeSisto et al., 2014). Fetal growth restriction (weight below
10th percentile for gestational age) affects approximately 10% of the nearly four million
births nationwide (Hamilton, 2017), with both immediate and long-term risks associated.
The percentage of infants with low birthweight (less than 2,500grams) has increased the
last two years following a seven year decrease (Hamilton, 2017).
Background
Preeclampsia is defined as hypertension after 20 weeks gestation with proteinuria
or signs of organ involvement, where GHTN only involves hypertension after 20 weeks.
Maternal risk factors for preeclampsia include pre-pregnant obesity, being nulliparous,
family history of hypertensive disorder in pregnancy, diabetes, and maternal age and are
similar to cardiovascular disease risks (Ramsay, Stewart, Greer, & Sattar, 2003). It is the
leading cause of maternal and fetal morbidity and mortality in pregnancy and affects nearly
10 million pregnancies worldwide (Foundation, 2013; Baha Sibai, Gus Dekker, & Michael
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Kupferminc, 2005). Preeclampsia accounts for one-third of preterm deliveries, one-fourth
of growth restricted infants, and 15-20% of maternal mortality in developed countries with
associated costs in the U.S in 2012 at $2.18 billion (Foundation, 2013; Baha Sibai et al.,
2005; Stevens et al., 2017). Women in developing countries are seven times more likely to
develop preeclampsia (Foundation, 2013). Preeclampsia also increases both maternal and
offspring risks for future hypertension, heart disease, stroke and type 2 diabetes (Ramsay
et al., 2003; Baha Sibai et al., 2005).
Another adverse pregnancy outcome is preterm birth (PTB) which occurs between
22 and 37 completed weeks of gestation. Early PTB occurs less than 34 weeks, while late
PTB is 34-36 weeks. Extremely preterm is <28 weeks, and very preterm 28-32 weeks
gestation. About half of all PTB are spontaneous, which occurs after spontaneous labor or
premature rupture of membranes. Provider initiated PTB may occur for medical (maternal
or fetal compromise) or non-medical (convenience or maternal request) reasons. The most
recent estimate reports costs of PTB at $26 billion per year in the U.S. ("Preterm Birth:
Causes, Consequences, and Prevention," 2006). It is a leading cause of infant mortality and
lifelong disability (Bolton, Bush, Hurst, Kotecha, & McGarvey, 2015; CDC, 2017b;
Heinonen et al., 2015; Luyckx, 2017; Nuyt, Lavoie, Mohamed, Paquette, & Luu, 2017).
Maternal history of prior PTB is the most significant risk factor for subsequent PTB, but
other known risks are maternal smoking, non-Hispanic black race, lower socioeconomic
status, pre-pregnant obesity, maternal infection, and maternal stress.
Gestational diabetes is characterized by insulin resistance and hyperglycemia in
pregnancy and increases maternal risk for preeclampsia, cesarean delivery and birth
trauma, infant risk of being large for gestational age, PTB, birth defects or respiratory
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distress (Catalano et al., 2012; C. Wang & Yang, 2016). It is typically diagnosed by oral
glucose tolerance test at 24-28 weeks gestation. Maternal risk factors for GDM are older
age, family history of diabetes, being overweight or obese, excessive weight gain during
pregnancy, and Asian, Pacific Islander, American Indian or non-Hispanic black
race/ethnicity (Pu et al., 2015). Long term risk for Type 2 diabetes is higher with pregnancy
complicated by GDM for both mother and offspring (DeSisto et al., 2014).
Less than optimal fetal or newborn growth is another common adverse pregnancy
outcome. Small for gestational age (SGA) are defined as below 10th percentile for gestation.
Growth restriction is present in about 10% of births in developed countries, and about six
times higher in developing countries (Saleem et al., 2011). In 2010, 27% of live births, or
32.4 million infants, were born SGA in low and middle-income countries, with 10.6 million
born term low birthweight (Lee et al., 2013). Poor uteroplacental perfusion and fetal
undernutrition are the pathophysiological causes for poor fetal growth. Growth restricted
fetuses are at increased risk for fetal or neonatal death, cognitive delay in childhood and
chronic diseases in adulthood (Salam, Das, & Bhutta, 2014). Growth restricted newborns
are at increased risk of complications such as hypoglycemia, hypothermia,
hyperbilirubinemia, seizure, and respiratory distress ("ACOG Practice bulletin no. 134:
fetal growth restriction," 2013). Risk factors for growth restriction include pregnancy
related hypertension (GHTN or preeclampsia), pre-gestational diabetes, tobacco, drug or
alcohol use during pregnancy, multiple gestation, African American race, lower
socioeconomic status and maternal infection (L. McCowan & Horgan, 2009). Diabetes
during pregnancy, whether onset is before pregnancy or after, is a risk factor for both
growth restriction and growth excess. Large for gestational age (LGA) is defined as above
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the 10th percentile for gestational age, and macrosomia is more than 4,000 grams (about 9
pounds) at birth regardless of gestational age. Large infants are at increased risk of birth
trauma, and hypoglycemia while maternal risk is increased for birth trauma and cesarean
delivery.
One prominent risk factor for adverse pregnancy outcomes is adequacy of
gestational weight gain. Gestational weight gain is simply how much weight the mother
gains over the course of pregnancy. The Institute of Medicine published guidelines in 2009
for appropriate GWG. Recommendations for appropriate GWG are based on pre-pregnant
body mass index (BMI) for underweight, normal weight, overweight or obese women.
More than optimal gains are associated with increased pregnancy risks such as
preeclampsia, GDM, and macrosomia/LGA, especially for overweight or obese women
(Flick, Brookfield, Tudela, Duthely, & González-Quintero, 2010; Frederick, Williams,
Sales, Martin, & Killien, 2008; Spiegler et al., 2013). Women who were underweight
and/or had suboptimal GWG had higher risk of SGA and PTB (Goldstein et al., 2017; Liu,
Dai, Dai, & Li, 2012).
Dysregulation of inflammatory state and oxidative stress are associated with
adverse gestational outcomes. Women with preeclampsia and preterm birth (PTB) have
higher expression of inflammatory cytokines and oxidative stress during pregnancy (Brou
et al., 2012; Bullen et al., 2013; Burton & Jauniaux, 2004; Cobo et al., 2013; CoussonsRead et al., 2012; Undurti N. Das, 2015; Han, Ha, Park, Kim, & Lee, 2011; Harmon et al.,
2016; Hecht et al., 2008; Moghaddam Banaem et al., 2012; Ruiz et al., 2012). Obesity prior
to pregnancy along with excess maternal weight gain also alters maternal inflammatory
status in pregnancy and increases risk for both PTB, gestational diabetes (GDM) and
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preeclampsia (Bullen et al., 2013; Cnattingius et al., 2013; Dong et al., 2017; Han et al.,
2011). Excess GWG is associated with altered inflammation and increased risk for PTB
(Chavan et al., 2015). Hyperglycemia and insulin resistance in pregnancy trigger
endothelial dysfunction and inflammation and increase the risk of preeclampsia (Catalano
et al., 2012; Ramsay et al., 2003).
Fruit and vegetable intake have been implicated in chronic disease incidence and
management. Intake of fruits and vegetables has been demonstrated to protect against type
2 diabetes, cancer and cardiovascular disease (Carter, Gray, Troughton, Khunti, & Davies,
2010; Cooper et al., 2012; He et al., 2004) possibly related to the antioxidant and antiinflammatory properties they possess (Wu & Schauss, 2012; Zhang et al., 2015). Though
fruits and vegetables alone or as part of a dietary pattern are known to impact other health
problems related to inflammation and oxidation, less is known about their influence on
pregnancy outcomes. Therefore, the purpose of this systematic review is to evaluate the
current state of the science on the impact of maternal dietary consumption of fruits and/or
vegetables on the incidence of PTB, GDM, preeclampsia, SGA, as well as GWG and
measures of inflammation or oxidative stress in pregnancy.
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Methods
The purpose of this systematic review is to investigate the influence of dietary fruit
and/or vegetable intake on perinatal outcomes and associated inflammation or oxidative
stress. The aims are to: 1. evaluate the relationship between fruit and vegetable intake and
adverse pregnancy and birth outcomes. 2. evaluate the relationship between fruit and
vegetable intake and inflammatory/oxidative stress biomarkers.
Databases searched were PubMed, CINAHL, and Medline. Search terms for dietary
intake were “fruit” or “vegetable”. The population of interest was during pregnancy terms
with modifiers were: “pregnan*”, “prenat*”, “gestat*”, or “maternal” were included. Based
on outcomes of interest the terms “preterm”, “premature”, “preeclampsia”, “diabetes”,
“inflammat*”, “oxidat*”, “IUGR”, “SGA”, “weight”, and “gain” were used. Searches were
connected by Boolean operators “AND” and “OR” to retrieve all possible relevant articles.
Articles were filtered to include the last 15 years, English only, and in humans only.
Primary experimental, observational, cross-sectional and case-control study designs were
included. There were 271 articles retrieved after duplicates were removed. Title and
abstract review were used to select 28 articles based on the following criteria for inclusion:
whole fruit or vegetable intake (not nutrients or extracts) alone as an independent variable;
one or more of the outcomes of interest as dependent variables (PTB, GWG, fetal growth
(IUGR/SGA), preeclampsia/GHTN, GDM, or inflammation/oxidative stress). Those
meeting inclusion criteria were saved in EndNote with full text publication obtained and
attached to the reference. Exclusion criteria applied to the remaining 28 articles upon full
article review were: an educational intervention was the independent variable (n=3), “fruit
drink”, fruit extract or macronutrient intake was used instead of fruit (n=4), or outcomes
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other than those of interest (n=2). In total, 19 articles were included in this systematic
review (Figure 3.1).
A data table was used to organize and synthesize the included studies based on
study location, sample type and size, study purpose, dietary measures, pregnancy outcome,
and key findings (Table 3.1). The outcomes of interest for this review were fruit and or
vegetable intake and the pregnancy outcomes of interest (PTB, GWG, fetal growth
(IUGR/SGA), preeclampsia/GHTN, GDM, or inflammation/oxidative stress). Data were
extracted and analyzed based on gestational outcome.
Quality assessment of all included publications was assessed based on study type
(observational cohort, cross-sectional and case-control studies). Newcastle-Ottawa scale
for case-control (Appendix A) and cohort studies (Appendix B) were used for their
respective study types, as well as a modified version for cross-sectional studies (Appendix
C). These scales evaluate quality based on participant selection, comparability of groups,
and outcome. Scores range from zero to nine with lower scores representing lower quality
observational studies. For the purposes of this review, high quality studies were scored
seven to nine, moderate quality four to six, and poor quality zero to three.
Dietary intake and birth outcome variables
Preeclampsia. All included studies evaluating preeclampsia as an outcome of
interest used the same criteria for diagnosis of preeclampsia: Hypertension with systolic
blood pressure of 140mmHg or higher and or diastolic blood pressure of 90 or greater on
two separate occasions at least four hours apart and occurring after 20 weeks gestation and
prior to labor, or after delivery, along with either proteinuria or other signs of multiorgan
involvement. Signs of multiorgan involvement were: acute renal insufficiency (defined as
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a new increase in serum creatinine concentration ≥100 µmol/L antepartum or >130 µmol/L
postpartum); liver dysfunction (defined as high transaminases, severe right upper quadrant
or epigastric pain or liver rupture); neurological symptoms (eclampsia, severe headache,
hyperreflexia, visual disturbance, or cerebral hemorrhage); blood disorders such as
thrombocytopenia (platelets <100,000), disseminated intravascular coagulation, or
hemolysis.
Fetal growth. Small for gestational age (SGA) was most often used to describe
infants with poor growth in utero. The infant weight at birth below the 10th percentile was
the primary characteristic and was usually adjusted for gestational age and sex of the infant.
In some instances, it was also adjusted based on maternal height, pre-pregnant weight, or
ethnicity. Low birthweight is sometimes used to define infant growth and is defined as
infants born weighing less than 2,500g regardless of gestational age. Individual
anthropometric measures such as birth weight, length or head circumference were used by
Loy et al to describe infant growth in relation to gestation (2011).
Gestational weight gain/adequacy. Gestational weight gain was calculated as the
maternal weight at delivery minus maternal weight prior to pregnancy. Maternal prepregnant weight was either self-reported or the measured weight at first prenatal visit was
used. Weight prior to delivery was either performed on a scale, or by patient self-report.
Pre-pregnant BMI was calculated in order to determine adequacy of weight gain and used
pre-pregnant weight and either measured height, self-report or medical record to determine
height. The formula for BMI is weight in kilograms divided by height(meters) squared.
The Institute of Medicine (IOM) guidelines for GWG were used in all included studies to
determine adequacy of maternal gain (Figure 3.2).
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Preterm birth. Gestational age was calculated from either the last menstrual period
of the mother or based on ultrasound measures. First trimester ultrasound is considered the
most accurate at estimating gestational age and was used to adjust due dates if this measure
varied from last menstrual period dates by more than a week. Preterm birth occurred if
gestational age was less than 37 weeks. One study focused on a specific category of PTB
with gestational age 32 weeks to 36 weeks 6 days and called late to moderate preterm birth
(LMPT) (Smith et al., 2015)
Inflammation/Oxidative stress. The two studies that measured inflammation in
pregnancy used maternal serum biochemical assays to evaluate the inflammatory state in
pregnancy. Maternal samples were collected at 14-16 weeks in one study (Vieira et al.,
2017), the other collected samples at approximately 30 weeks gestation (Hrolfsdottir et al.,
2016). Six biomarkers were measured by Hrolfsdottir et al. (2016), and 54 were included
by Vieira et al (2017). There were no studies evaluating oxidative stress and diet in
pregnancy.
Gestational Diabetes Mellitus. Impaired glucose tolerance meeting criteria for
GDM was defined as maternal fasting glucose ≥95mg/dl (high glucose) or adequate if level
was below 95mg/dl, or as glucose tolerance test level of ≥140mg/dl compared to normal
or adequate if glucose was less than 140mg/dl. The American Congress of Obstetricians
and Gynecology (ACOG) supports two step testing, first with screening with 50 g oral
glucose followed by serum glucose measure an hour later ("ACOG Practice Bulletin No.
190: Gestational Diabetes Mellitus," 2018). Abnormal results are considered above
140mg/dl and indicate further testing using a 100g three-hour oral glucose challenge test.
Abnormal results on two or more values for either fasting (above 95-105mg/dl), hour one
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(above 180-190mg/dl), hour two (above 155-165mg/dl), or hour 3(above 140-145mg/dl)
indicate GDM is present. Values used vary based on different laboratory standards and
which of two criteria are used for comparison.
Dietary intake of fruits and vegetables. Significant heterogeneity of dietary
measures existed among studies. Intake was measured most often using food frequency
questionnaire (FFQ), but also included four-day food record or other investigator
determined methods. They were either self-administered or by interview. Validated dietary
tools were used in less than half the included studies. Timing of administration of
questionnaires occurred through all trimesters and postpartum; the time period of interest
could be from a few days up to a full year prior to the assessment. Dietary intake was
evaluated as continuous intake or categorized based on volume or frequency of intake and
adequacy.
Results
Study Characteristics
Studies included in the review were published 2004-2017 (Table 3.1). There were
12 cohort studies (quality score range 6-8; mean=6.8), four cross-sectional studies (quality
score range 6-7; mean=6.8), three case-control studies (quality score range 5-9; mean=6.3)
(Appendix E.).
All but four of the included studies were conducted in developed countries (Asefa
& Nemomsa, 2016; Endeshaw, Abebe, Bedimo, & Asart, 2015; Longo-Mbenza, KadimaTshimanga, Buassa-bu-Tsumbu, & M'Buyamba, 2008; Loy et al., 2011). Sample sizes
ranged from 95 to 43,585 pregnant women. Dietary data were collected from early
pregnancy to after delivery and primarily self-reported. About half the researchers used
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validated dietary tools, with most of those not validated for use in pregnant women. Though
19 publications were included in this review, four used a single database from New Zealand
(SCOPE) (Kenny et al., 2014; L. M. McCowan et al., 2010; North et al., 2011; Vieira et
al., 2017). Five studies originated in Scandinavian countries (Bärebring et al., 2016;
Hrolfsdottir et al., 2016; Merkx, Ausems, Bude, de Vries, & Nieuwenhuijze, 2015;
Mikkelsen, Osler, Orozova-Bekkevold, Knudsen, & Olsen, 2006; Myhre et al., 2013). Two
studies were conducted in Ethiopia (Asefa & Nemomsa, 2016; Endeshaw et al., 2015).
These two plus Longo-Mbenza et al. (2008) originated in African countries. Two each from
Asia (Loy et al., 2011; J. Wang et al., 2017) and Europe (Ramon et al., 2009; Smith et al.,
2015) were included as well. Six studies evaluated gestational outcomes that included
preeclampsia or hypertension in pregnancy; five included GWG and six fetal growth. Four
studies included PTB, two measured inflammation, and a single study evaluated maternal
glucose tolerance/GDM.
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Table 3.1 Characteristics of included studies on fruit and vegetable intake and birth outcomes
Location

Sample

Asefa, F., &
Nemomsa, D.
(2016).

Ethiopia.

Women delivering at
healthcare facilities in
Ethiopia (N=411).

Bärebring, L.,
Brembeck, P., Löf,
M., Brekke, H. K.,
Winkvist, A., &
Augustin, H.
(2016).

Sweden.

Endeshaw, M.,
Abebe, F.,
Bedimo, M., &
Asart, A. (2015).

Ethiopia

Guilloty, N. I.,
Soto, R., Anzalota,
L., Rosario, Z.,
Cordero, J. F., &
Palacios, C.
(2015).

Puerto
Rico

40

Reference

Purpose

Dietary assessment

Assess weight gain
Interview after
during pregnancy and its delivery to evaluate
dietary pattern average
associated factors.
throughout pregnancy.

Swedish pregnant women Investigate if food intake
who perceive themselves
is associated with
as healthy, having an
gestational weight gain
uncomplicated pregnancy,
(GWG) in Swedish
in gestational week 35–37
women
at the study visit, between
25 and 40 years of age
(N=95).
Pregnant women who
Determine the effects of
stayed in the region at
dietary habits on
least 6 months and
preeclampsia.
received prenatal care or
delivered in public health
facilities (N=453).
Pregnant women age 18Describe the dietary
40 with healthy
patterns in healthy
pregnancies and had
pregnant woman and
completed dietary data determine the association
(n=160).
between diet factors, prepregnancy BMI and sociodemographic
characteristics with GWG.

Outcome

Results

GWG

Those who
consumed fruit and
vegetables and meat
at least weekly were
more likely to have
adequate gains.
No significant
relationships
between GWG and
fruit and vegetable
intake.

At enrollment (3537 weeks) 4-day
food record (four
consecutive days,
including at least 1
weekend day).

GWG

Dietary data collected
at enrollment (20
weeks gestation to 48
hours postpartum) by a
trained midwife using
pretested tools.
Dietary assessment
20-28 weeks
gestation using selfadministered FFQ.

PE

GWG

Intake of fruit or
vegetables at least 3
times/week was
protective against
PE (AOR .46 and
.51 respectively).
No differences in
GWG based on fruit
or vegetable intake.

Quality/
type
7; cs

7; coh

9; cc

6; coh
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Reference

Location

Sample

Purpose

*Hrolfsdottir, L.,
Schalkwijk, C. G.,
Birgisdottir, B. E.,
Gunnarsdottir, I.,
Maslova, E.,
Granström, C., . . .
Halldorsson, T. I.
(2016).

Denmark

Pregnant
women with
singleton
gestation and
received care at
a clinic in
Aarhaus
(N=965).

Examine the
relationship between
GWG, diet and
inflammation in
pregnancy.

Kenny, L. C.,
Black, M. A.,
Poston, L., Taylor,
R., Myers, J. E.,
Baker, P. N., . . .
North, R. A.
(2014).

New Zealand,
Australia,
United
Kingdom, and
Ireland. Part
of SCOPE
cohort.

Healthy
nulliparous
women with
singleton
pregnancies
(N=5,623).

Longo-Mbenza,
B., KadimaTshimanga, B.,
Buassa-buTsumbu, B., &
M'Buyamba, K.,
Jr. (2008).

Democratic
republic of
Congo

Pregnant
women who did
not have
chronic
hypertension
(N=238).

Develop a
multivariable
predictive model for
the prediction of
preeclampsia; and to
develop
multivariable
models to predict
specific types of
preeclampsia.
Assess the incidence
of GHTN, and if
vegetable intake and
physical activity are
protective against
GHTN among rural
women from the
Democratic republic
of Congo.

Dietary
assessment
Dietary intake
was collected by
self- administered
FFQ and face to
face interview in
gestational week
30.

Outcome

Results

GWG and
maternal serum
markers of
inflammation.

Plasma CRP and SAA
were 3% higher and
IL-8 was 2% lower
for each 1kg increase
in GWG the first 30
weeks of pregnancy.
Intake of plant protein
was inversely
associated with CRP
and SAA compared to
animal protein intake.
High intake of fruit (≥
3 pieces of fruit/day)
in mid pregnancy was
protective against of
PE and term PE.
Endoglin was higher
in those with earlyonset PE. IL-1Ra was
lower in those with
preterm PE.
Consuming at least 3
servings of vegetables
per day was
protective against
preeclampsia.

Dietary
information using
FFQ was
collected 14-16
weeks.

PE and timing
of onset.

First trimester
dietary
questionnaire.

GHTN/PE

Quality/
type
6; cs

7; coh

6; coh

Table 3.1 (continued) Characteristics of included studies on fruit and vegetable intake and birth outcomes

42

Reference

Location

Sample

Purpose

Dietary
assessment
Maternal
interview was
used to
complete FFQ
at enrollment
(28-38 weeks).

Outcome

Results

Loy, S. L.,
Marhazlina, M.,
Azwany, Y. N., &
Hamid Jan, J. M.
(2011).

Malaysia

Healthy pregnant women
with singleton gestation
who were Malaysian
citizen/ethnicity age 1940 and planned to give
birth at Universiti Sains
Malaysia Hospital
(N=121).

Investigate the
effect of
maternal diet
on birth size
among
Malays.

SGA

Identify risk
factors among
healthy
nulliparous
women for
SGA.

Dietary
information
collected at
15±1 week and
20±1 week.

SGA

Gain
knowledge of
healthy
pregnant
women's
GWG
and identify
factors
associated
with healthy
GWG.

Dietary intake
of fruit,
vegetables and
fish by either
mail or phone
interview using
FFQ.

GWG

Leafy vegetables were
positively associated with
head circumference.
Tuberous vegetables were
positively associated with
birth length and head
circumference. Fruit intake
was positively associated
with larger babies.
Those with normotensive
SGA were less likely to eat
3 servings/day of green
leafy vegetables prior to
pregnancy vs normotensive
non-SGA. Those eating
fruit less than once weekly
pre-pregnancy had twice the
risk of normotensive SGA.
Pre-pregnant BMI, nor diet
were associated with
adequacy of GWG.

McCowan, L. M.,
Roberts, C. T.,
Dekker, G. A.,
Taylor, R. S.,
Chan, E. H.,
Kenny, L. C., . . .
North, R. A.
(2010).

New Zealand,
Australia, the
United
Kingdom, and
Ireland Database
is part of
SCOPE trial.

Healthy nulliparous
women with singleton
pregnancy at 15 ± 1
weeks of gestation (N =
3560).

Merkx, A.,
Ausems, M.,
Bude, L., de Vries,
R., &
Nieuwenhuijze, M.
J. (2015).

Netherlands
September
2012-November
2012.

Healthy pregnant women
of all gestational ages
who agreed to participate
and completed
questionnaires (N=550).
Excess GWG n=173.

Quality/
type
6; cs

8; coh

7; cs
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Reference

Location

Sample

Purpose

Mikkelsen, T. B.,
Osler, M.,
OrozovaBekkevold, I.,
Knudsen, V. K.,
& Olsen, S. F.
(2006).
Mitchell, E. A.,
Robinson, E.,
Clark, P. M.,
Becroft, D. M.,
Glavish, N.,
Pattison, N. S., . .
. Wild, C. J.
(2004).
Myhre, R.,
Brantsaeter, A.
L., Myking, S.,
Eggesbo, M.,
Meltzer, H. M.,
Haugen, M., &
Jacobsson, B.
(2013).

Denmark. Part
of Danish
National Birth
Cohort
(MoBa).

Pregnant women who
had singleton live
births were included in
the analyses
(N=43,585).

Examine the
relationship
between fetal
growth and fruit
and vegetable
intake.

New Zealand

Pregnant women who
delivered singleton
gestation at term
(n=844 SGA; n=870
AGA).

North, R. A.,
McCowan, L. M.,
Dekker, G. A.,
Poston, L., Chan,
E. H., Stewart, A.
W., . . . Kenny, L.
C. (2011).

Dietary
assessment
Dietary data
collected at 25
weeks using
validated selfadministered
FFQ.

Evaluate the
FFQ completed at
effect of
enrollment in
maternal diet
early pregnancy
during
(mean 8.2± 1.9
pregnancy and weeks gestation),
the risk of
and after delivery
delivering an
(mean 1.4±1.3)
SGA baby.
weeks.
Norway. Part
Healthy pregnant
Evaluate the
Valid dietary
of Norwegian women age 20-35 with influence of foods
FFQ selfMother and
singleton gestation with with antimicrobial administered at
and prebiotic
Child Cohort
complete dietary and
approximately
components on
(MoBa).
general health
17-22 weeks
risk of
questionnaires
gestation.
spontaneous PTB.
(N=18,888).
Spontaneous PTB
n=950.
New Zealand,
Healthy nulliparous
Develop a
Dietary FFQ
Australia,
women with singleton predictive model
was collected
United
gestation pregnancy
for preeclampsia
14-16 weeks
Kingdom,
(N=4,961).
based on clinical
gestation.
Ireland. Part of
risk factors for
SCOPE
nulliparous
dataset.
women and to
identify a
subgroup at
increased risk.

Outcome

Results

Quality/
type
6; coh

Birthweight

Higher green leafy
vegetable intake was
associated with increase
in birth weight.

SGA

No significant effect of
diet on fetal growth.

5; cc

PTB

Higher intake of allium
and dried fruit lowered
risk of PTB.

7; coh

PE

Consuming more than 3
servings/day of fruit was
protective against PE.

6; coh

Table 3.1 (continued) Characteristics of included studies on fruit and vegetable intake and birth outcomes
Location

Sample

Purpose

Ramon, R.,
Ballester, F.,
Iniguez, C.,
Rebagliato, M.,
Murcia, M.,
Esplugues, A., . .
. Vioque, J.
(2009).

Spain.

Healthy pregnant
women at 10-13 weeks
gestation at least 16
years old with
singleton gestation
(n=787). SGA weight
11.5%; SGA length
5.7%.

Determine if
fruit and
vegetable intake
during
pregnancy was
associated with
fetal size at
birth.

Smith, L. K.,
Draper, E. S.,
Evans, T. A.,
Field, D. J.,
Johnson, S. J.,
Manktelow, B.
N., . . . Boyle, E.
M. (2015).

United
Kingdom.

All births 32-36+6
weeks (N=1,887).

Evaluate the
association
between lifestyle
factors and
LMPT.

Dietary
assessment
FFQ completed
first trimester at
10-13 weeks
and in the third
trimester 28-32
weeks

Outcome

Results

Infant birth
size (length,
weight,
SGA).

Low first and third
trimester vegetable
intake was associated
with lower mean
birthweight vs those
with higher intake.
Higher vegetable intake
during the first trimester
lowered SGA risk for
weight. Higher
vegetable intake during
the third trimester for
was associated with
lower risk for SGA for
length.
Those who ate 5
portions of fruits and
vegetables per day less
than weekly had higher
risk for LMPT birth than
those who ate them
more frequently.
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Reference

Maternal
interview soon
after delivery
established
dietary intake.

LMPT birth
(32+0 to
36+6 weeks
gestation).

Quality/
type
8; coh

6; coh
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Reference

Location

Sample

*Soto, R.,
Guilloty, N.,
Anzalota, L.,
Rosario, Z.,
Cordero, J. F., &
Palacios, C.
(2015).

Puerto Rico.

Pregnant women 18-45
years old, <20 weeks
gestation with
spontaneous healthy,
uncomplicated
pregnancy who lived in
northern karst area
(N=180).

Vieira, M. C.,
Poston, L., Fyfe,
E., Gillett, A.,
Kenny, L. C.,
Roberts, C. T., . .
. Pasupathy, D.
(2017).

New Zealand,
Australia,
United
Kingdom, and
Ireland. Part of
SCOPE cohort.

*Wang, J., Zeng,
Y., Ni, Z. M.,
Wang, G., Liu, S.
Y., Li, C., . . .
Nie, S. F. (2017).

China

Purpose

Dietary
assessment
Dietary data
collected 20-24
weeks using
validated selfadministered
FFQ.

Describe dietary
patterns of
Puerto Rican
pregnant women
and analyze the
association
between
protective and
non-protective
diet factors and
pregnancy
related
measurements.
Healthy nulliparous
Compare early
Dietary
pregnant women with pregnancy clinical assessment at
risks and
singleton gestation
14-16 weeks by
biomarkers
who were normal
maternal
between women
weight (n=3,106) or
interview.
with obesity and
obese (n=834) prior to
pregnancy (N=3,940). those with normal
BMI to determine
risk factors for
later preeclampsia.
Singleton newborn
Explore factors
Interview by a
babies without birth
associated with
trained
defects born at Women
PTB and low
investigator
and Children Medical.
birth weight.
after delivery to
matched with normal
estimate intake
birth weight controls
of fruits and
(n=708), as were PTB
vegetables
cases (n=472) with
term (n=708) controls.

Outcome

Results

Quality/
type
7; coh

Maternal
glucose
tolerance,
blood
pressure, and
length of
gestation.

Those who ate
vegetables at least
weekly were more likely
to have high 1-hour
glucose test than those
who ate them less often.

PE and
markers of
inflammation.

Eating 3 or more pieces
of fruit per day predicted
significantly lower odds
of developing
preeclampsia.

8; coh

Birth weight
and
gestational
age.

Consuming 250 g or
more of fruit per day in
the first trimester
increased odds of LBW.

5; cc

Index:GWG-gestational weight gain; FFQ-food frequency questionnaire, CRP-c reactive protein; SAA-serum amyloid A; PE-preeclampsia; IL-1Ra-interleukin 1 receptor
agonist; GHTN-gestational hypertension; SGA-small for gestational age; BMI-body mass index; cc-case control study; coh-cohort study; cs-case study.

Preeclampsia
There were six articles included in the review examining the influence of fruit and
vegetable intake with risk for preeclampsia or maternal blood pressure (Endeshaw et al.,
2015; Kenny et al., 2014; Longo-Mbenza et al., 2008; Soto et al., 2015; Vieira et al., 2017).
Five were cohort and one was case control. Fruit or vegetable intake alone was generally
associated with lower risk for preeclampsia in multivariate analyses. Specifically, higher
vegetable intake decreased odds of preeclampsia by 20-54% (Brantsaeter et al., 2009;
Endeshaw et al., 2015; Longo-Mbenza et al., 2008; Torjusen et al., 2014). Consuming three
or more pieces of fruit per day was also protective against preeclampsia (Kenny et al.,
2014), with researchers in one study reporting that eating fruit at least three times weekly
lowered the odds of preeclampsia by about half (Endeshaw et al., 2015). High maternal
blood pressure was not related to dietary intake based on bivariate analyses by Soto et al
(2015). This was only included study not using multivariate analyses including covariates.
Results from all studies investigating the effect of maternal diet on preeclampsia
using multivariate analyses, support the beneficial effects of vegetables in maternal diet at
reducing risk for development of this dangerous condition. Consumption of at least three
servings per day of either fruit or vegetables was the most common amount reported to
reduce risk. No increased risk of preeclampsia was reported based on intake of fruit or
vegetable in any of the included studies. These findings are consistent with a recent metaanalysis of observational studies examining the effect of diet on hypertensive disorders of
pregnancy (Schoenaker, Soedamah-Muthu, & Mishra, 2014). Their findings suggested that
higher intakes of fruits and vegetables were beneficial on preeclampsia.
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Fetal growth
Six articles reported on the impact of fruit and vegetable intake on fetal growth
(Loy et al., 2011; L. M. McCowan et al., 2010; Mikkelsen et al., 2006; Mitchell et al., 2004;
Ramon et al., 2009; J. Wang et al., 2017). Three cohort studies, two case control and one
case study comprise the group evaluating this outcome. Pre-pregnant fruit intake was
associated with two-fold lower risk of SGA in women with normal blood pressure (L. M.
McCowan et al., 2010). Birthweight also significantly increased with higher fruit intakes
(Loy et al., 2011; Mikkelsen et al., 2006), as did birth length and head circumference
(Mikkelsen et al., 2006). Maternal intake of at least three servings of green leafy vegetables
per day resulted in a greater than 50% reduction in risk of SGA (L. M. McCowan et al.,
2010). Loy et al (2011) reported a 1.78 centimeter increase in head circumference for every
10 gram increase in green leafy vegetable intake (p=.04). Those who had highest vegetable
intake in their first and third trimester had lower risk for SGA overall (OR=5.5), as well as
adjusted for length and weight (first trimester: length OR=1.6, weight OR=3.7; third
trimester: length OR=5.5, weight OR=2.1) compared to those with the lowest intakes
(Ramon et al., 2009). However, Wang, et al. reported a 70% increased risk of LBW with
300 or more grams of fruit intake per day in the first trimester of pregnancy (2017). Low
birthweight may not be representative of optimal growth as it is not gestational age
adjusted. No differences were reported in incidence of SGA based on intake by Mitchell et
al. (2004).
Overall, improved fetal growth and reduction in risk for SGA was supported by the
inclusion of fruit or vegetables in maternal diet by most of the studies, which also had
moderate to high quality scores (range 6-8). The two studies that reported either increased
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risk or no difference represented the lowest quality scores of those included in this review
(five for both). Intake of fruit less than weekly increased risk of SGA, while higher intakes
of fruit was beneficial in increasing birth size and reducing risk for SGA. Intake of green
leafy vegetables and onion type vegetables also predicted of lower risk of SGA. These
findings are consistent with a prior review on the impact of maternal diet on birthweight
which supported the ability of dietary patterns including fruits and vegetables to promote
optimal birthweight (Grieger & Clifton, 2014).
Gestational Weight Gain
Five articles reported findings of the effect of fruit and/or vegetable intake on GWG
(Asefa & Nemomsa, 2016; Bärebring et al., 2016; Guilloty et al., 2015; Hrolfsdottir et al.,
2016; Merkx et al., 2015). Three case studies and two cohort studies evaluated GWG. In
four of the five included studies, one-fourth to half the women exceeded the IOM
guidelines for GWG (Bärebring et al., 2016; Guilloty et al., 2015; Hrolfsdottir et al., 2016;
Merkx et al., 2015). Substituting energy from plant protein for animal protein reduces risk
of excess GWG by 32%, but no differences were reported based solely on vegetable intake
(Hrolfsdottir et al., 2016). Combined intake of fruit and vegetables at least once a week
decreased the odds of inadequate GWG for women in Ethiopia (AOR 2.7, CI 1.2-6.6,
p=.05), as did weekly meat intake (Asefa & Nemomsa, 2016). This study was conducted
in Ethiopia and inadequate GWG was more concerning than excessive gains (69.3%
inadequate vs 2.7% excessive). Adequacy, excess or inadequacy of GWG did not differ
significantly based solely on fruit or vegetable intake in pregnant women in four of the five
studies (Bärebring et al., 2016; Guilloty et al., 2015; Hrolfsdottir et al., 2016; Merkx et al.,
2015).
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Recent studies confirm that appropriate GWG was not predicted by maternal fruit
or vegetable intake. A single study suggests a beneficial effect for fruit intake at least three
times weekly in those at risk of inadequate GWG.
Preterm Birth
Researchers in four studies evaluated the relationship between fruit and vegetable
intake and PTB (Myhre et al., 2013; Smith et al., 2015; Soto et al., 2015; J. Wang et al.,
2017). Intake of dried fruit and onion-type vegetables was associated with 18% lower odds
of PTB (Myhre et al., 2013). The intake of onion-type vegetables also significantly lowered
the odds of early PTB (28-32 weeks)(OR .47), as well as late PTB (32-37 weeks)(OR=.83)
(Myhre et al., 2013). Those who ate five servings per day of fruits and vegetables less than
once a week had 31% higher risk of PTB (Smith et al., 2015). However, intake of fruits
and vegetables did not affect risk for PTB based on findings from two included studies
(Soto et al., 2015; J. Wang et al., 2017). Soto et al. based findings on bivariate analyses
only and was one of the two lowest studies in quality rankings included in the review
(score=5). Two studies collected dietary data after delivery which could introduce recall
bias (Smith et al., 2015; J. Wang et al., 2017).
The evidence supporting lower risk of PTB with increased maternal intake of fruits
or vegetables is inconclusive. The findings from two studies are promising, but more highquality evidence is needed to either support or refute benefits.
Gestational Diabetes
A single publication included glucose metabolism as an outcome of interest and
fruit or vegetable intake as independent variables (Soto et al., 2015). This cohort study
used bivariate analyses to evaluate associations between dietary factors and specific
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outcomes. No bivariate associations between fruit and or vegetable intake and fasting
glucose levels were found. High one-hour glucose challenge tests (>140mg/dl) were more
common among those eating vegetables at least weekly (60.5%) than those who consumed
them no more than monthly (39.5%, p=.008).

The results of this single study are

insufficient to base any conclusions on.
Inflammation
There were no publications that evaluated the effect of fruit or vegetable intake on
biomarkers of inflammation or oxidative stress.
Discussion
This review shows a limited amount of evidence existing on the impact of fruit or
vegetable intake on pregnancy and birth outcomes. The few available observational studies
support potential benefits to improved maternal intakes of these foods on healthier
pregnancy and better birth outcomes. Recent studies confirm that increased fruit or
vegetable intake is beneficial at reducing risk of preeclampsia and promoting optimal fetal
growth. There was no dietary impact on GWG from fruit or vegetable intake. The benefits
of fruit or vegetable intake on GDM, PTB and inflammation is inconclusive either due to
conflicting findings or lack of available evidence.
These findings are consistent with other reviews that support a relationship between
diet and health. Chronic diseases such as cardiovascular disease, hypertension, obesity and
type 2 diabetes are often treated, at least in part, through dietary management. These
diseases are associated with chronic inflammation in the body that may promoted by high
intake of refined grains and sugars, processed foods, and red meat (Barbaresko, Koch,
Schulze, & Nothlings, 2013), while those high in fruits, vegetables, whole grains, low fat
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dairy and lean meats reduce inflammation and risk for chronic diseases and death
(Barbaresko et al., 2013; Carter et al., 2010; Casas et al., 2014; Cooper et al., 2012; Ledoux,
Hingle, & Baranowski, 2011; B. Li, Li, Wang, & Zhang, 2016; Liyanage et al., 2016;
McMacken & Shah, 2017). Diets high in fruits and vegetables are rich in phytochemicals
that may attenuate the inflammatory response in chronic diseases (Griffiths et al., 2016;
Islam et al., 2016; Salaritabar et al., 2017). Obesity incites inflammation and oxidative
stress in the body as well, which may also be diminished by intake of foods rich in
flavonoids (Sharma, Chung, Kim, & Hong, 2016; Yeon, Kim, & Sung, 2012b). Increased
intake of fruits and vegetables may also promote healthier weight, and aid weight loss
(Bertoia et al., 2016; He et al., 2004; Ledoux et al., 2011). However, a paradoxical
relationship may exist between fruit intake and obesity, with increased intake being
detrimental to weight (Sharma et al., 2016).
Strengths
This review is the first to evaluate the impact of fruit and or vegetable intake only
on multiple gestational outcomes and inflammation in pregnancy. This is a comprehensive
review including 15 years of research. The exclusion of dietary patterns allows
generalizations not possible with inclusion of multiple foods and food groups.
Limitations
Some limitations of the research included in this review are the availability of
observational studies only. Observational studies provide evidence to support future
controlled trials to confirm or refute causal relationships and randomized controlled trials
are often not feasible in this population. Study enrollment is limited until after diagnosis of
pregnancy, and often longer if study exclusions include multiple gestation or miscarriage.
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The outcome interest often occurs well into pregnancy or even after delivery. Preeclampsia,
PTB, GDM, GWG, and poor fetal growth are infrequent occurrences and necessitate either
large sample sizes to have enough statistical power, or retrospective analyses to identify
cases. In addition, most of the included studies failed to adequately control for known risk
factors.
Bias in study design is another limitation. Sampling was most often based on a
geographical location or ethnic group with voluntary recruitment which introduces
sampling bias. Samples were primarily non-Hispanic white women from developed
countries where nutritional deficiencies are uncommon. The researchers often failed to
control for other factors affecting both intake and birth outcomes. Dietary data collection
often used non-validated instruments, performed at differing gestational ages often remote
from the period of interest which promotes both random and systematic measurement
errors. A single baseline dietary assessment my not adequately reflect the adaptations
women make to their diet to either improve outcomes or reduce symptoms such as nausea.
Dietary assessment varied and used FFQ, interview, recall and food record. Variation also
existed in how intake was quantified and included use of quantiles, means, medians or
established dietary recommendations used to determine adequacy.
Implications of findings for practice/education
Improved maternal intake of fruits and vegetables has potential to reduce risk for
some adverse perinatal outcomes. Dietary assessment early in pregnancy should be
performed to identify those with low intakes. Pregnant women, especially those at risk for
preeclampsia or poor fetal growth, should be encouraged to eat a diet rich in fruits and
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vegetables. Fruit intake should be encouraged, or supplemental food provided, for those at
risk of inadequate GWG.
The small number of available studies on maternal dietary fruit and vegetable
intake, gestational outcomes and inflammation is evidence of need for future research in
this area. Further research is needed using ethnically diverse populations in non-European
countries, especially the U.S., which is disproportionately affected by adverse maternal and
fetal outcomes and was minimally represented in this review. More representative samples
including those with both high and low risk for adverse outcomes are needed. African
American pregnancies are affected by preeclampsia and PTB at much higher rates than
their peers, and Hispanic immigrants tend to have better birth outcomes than native born
Americans (CDC, 2017a, 2017b; Hamilton, 2017; H. B. Martin JA, Osterman MJK, 2017).
Those from differing marital and socioeconomic backgrounds require evaluation as well to
determine the dietary effects for other risk profiles as well. Multiple assessments of
maternal dietary intake and biomarkers over the course of pregnancy would allow
researchers to examine the associations between diet and inflammation over time toward
the outcome of pregnancy. Confirmatory findings in a more representative population
could enable clinical interventions and policy recommendations to improve nutrition in
pregnant women and decrease risk for adverse gestational and birth outcomes. The paucity
of available evidence necessitates future studies on dietary factors affecting perinatal
outcomes.
Conclusion
This review evaluated the relationship between maternal fruit and vegetable intake
and adverse pregnancy and birth outcomes and determined that increased intake is

53

associated with decreased risk for preeclampsia and poor infant growth. However, the
paucity of evidence necessitates interpreting the overall impact of diet on gestational
outcomes with caution. The impact of maternal intake on PTB, GDM is inconclusive due
to limited evidence. Fruit and vegetable intake did not affect GWG adequacy. In addition,
the relationship between fruit and vegetable intake on regulation of inflammatory and
oxidative stress biomarkers was not evaluated due to lack of available evidence. Further
research is needed using more consistent procedures and measures in more diverse
populations to confirm or refute these findings. The impact of fruit or vegetable intake on
inflammation and oxidative stress is also a future pathway for research as inflammation
may play a crucial role in healthy gestational outcomes.

Copyright © Lori Ellen Ogden 2019
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Figure 3.1 Flow of articles
271 relevant articles retrieved- PubMed,
CINAHL, Medline

Title review,
remove duplicates

Inclusion criteria: fruit
or vegetable intake as
independent variable;
gestational outcomes
as dependent variable
(PTB, GDM, GWG, PE,
fetal growth,
inflammation)

71-abstract review

Articles not meeting
criteria:

27 full text
assessed

Fruit drinks=4
Effect of intervention=3
Other outcomes=2

19 articles included in review of fruit or vegetable intake and pregnancy (* articles included
in >1 category)

Gestational
diabetes:
*N=1

Gestational
weight gain:
N=4

Preterm
birth:
*N=4

Fetal
growth/size:
*N=6
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Preeclampsia:
*N=6

Inflammation/
oxidative
stress:
*Fruit/veg=3

Figure 3.2 Institute of Medicine Weight Gain Recommendations for Pregnancy
Prepregnancy Weight
Category

Body Mass
Index*

Recommended
Range of
Total Weight (lb)

Recommended Rates
of Weight Gain† in the
Second and Third
Trimesters (lb)
(Mean Range [lb/wk])

Underweight

Less than 18.5

28–40

1 (1–1.3)

Normal Weight

18.5–24.9

25–35

1 (0.8–1)

Overweight

25–29.9

15–25

0.6 (0.5–0.7)

11–20

0.5 (0.4–0.6)

Obese (includes all classes) 30 and greater

*Body mass index is calculated as weight in kilograms divided by height in meters squared or as
weight in pounds multiplied by 703 divided by height in inches.
†
Calculations assume a 1.1–4.4 lb weight gain in the first trimester.
Modified from Institute of Medicine (US). Weight gain during pregnancy: reexamining the
guidelines. Washington, DC. National Academies Press; 2009. ©2009 National Academy of
Sciences.
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CHAPTER FOUR: Fruit and Vegetable Intake in Pregnancy is Associated with
Inflammation, and Risks for Preterm Birth and Gestational Hypertension
Introduction
Fruit and vegetable intake are considered important components of a healthy diet
and are especially important during pregnancy. Consuming enough amounts of fruits and
vegetables may reduce the risk of adverse birth outcomes. A diet rich in fruit and vegetable
intake may regulate inflammation in the body as well.
In 2015, only 12.2% of adults met fruit intake recommendations while 9.3% met
vegetable intake recommendations (Lee-Kwan, Moore, Blanck, Harris, & Galuska, 2017).
Nutritional deficiencies due to poor maternal intake may increase risk of poor gestational
outcomes such as preterm birth, gestational diabetes and preeclampsia (Kibret, Chojenta,
Gresham, Tegegne, & Loxton, 2018; Schoenaker et al., 2014; Shin, Lee, & Song, 2015).
Diet also influences immune function (Barbaresko et al., 2013; Wu & Schauss,
2012). During pregnancy, dysregulation in immune functions increases susceptibility of
perinatal infections as well as other adverse birth outcomes including preterm birth and
hypertension in pregnancy. Due to the breadth of this topic, this paper will examine these
two commonly occurring perinatal outcomes (preterm birth and hypertensive disorders)in relation to maternal fruit and vegetable intake during pregnancy. These adverse perinatal
outcomes have also been linked to inflammation (Aggarwal et al., 2019; Harmon et al.,
2016; Lyon et al., 2010), likely affected by dietary intake (Wu & Schauss, 2012).
Background
Research examining the nutritional influence of fruit and vegetable intake on
hypertensive disorders of pregnancy is limited. Hypertensive disorders of pregnancy are a
group of disorders exclusive to pregnancy (preeclampsia/eclampsia, preeclampsia
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superimposed on chronic hypertension, and gestational hypertension). Gestational
hypertension is defined as maternal systolic blood pressure of 140 or higher or diastolic of
90 or higher from two separate readings at least four hours apart after 20 weeks gestation.
Preeclampsia occurs when gestational hypertension criteria are present as well as
proteinuria or other signs of multiorgan involvement. Signs of multiorgan involvement are
acute renal insufficiency (defined as a new increase in serum creatinine concentration ≥100
µmol/L antepartum or >130 µmol/L postpartum), blood disorders such as low platelets
(<100,000mg/dl), disseminated intravascular coagulation, or hemolysis, liver dysfunction
(transaminases two times normal limits, severe right upper quadrant/epigastric pain or liver
rupture), central nervous system involvement (eclampsia, severe headache, hyperactive
reflexes, visual disturbance, or cerebral bleeding). Preeclampsia may occur either after 20
weeks gestation and prior to the onset of labor or up to six weeks postpartum.
Preeclampsia affects 2-5% of pregnancies in industrialized nations worldwide,
while women in developing countries have nearly seven times the risk (Foundation, 2013).
Preeclampsia costs an estimated $2.18 billion in healthcare costs over usual pregnancy care
costs annually in the United States (Stevens et al., 2017), and affects 10 million pregnancies
worldwide (Foundation, 2013). Hypertensive disorders of pregnancy were responsible for
approximately 7% of pregnancy related deaths between 2011-2015 in the U. S. according
to the CDC (Petersen et al., 2019), and account for 76,000 of maternal deaths and 500,000
fetal deaths per year worldwide (Foundation, 2013). Preeclampsia also accounts for
approximately 15 % of preterm births in the United States according to the March of Dimes
(2017). Women who have preeclampsia may also be at increased risk for heart attack or
stroke in the future (Ramsay et al., 2003).
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Of the few studies examining the relationship between maternal diet and
hypertension, the majority focus on increased consumption of fruits and vegetables
decreasing odds of preeclampsia by 20-54% (Brantsaeter et al., 2009; Endeshaw et al.,
2015; Longo-Mbenza et al., 2008; Torjusen et al., 2014). Eating fruit at least three times
weekly also lowered the odds of preeclampsia by nearly half (Endeshaw et al., 2015).
Conversely, research by Soto et al (2015) did not find an association between fruit or
vegetable intake and maternal blood pressure.
Preterm birth occurs prior to 37 completed weeks of gestation and may occur either
spontaneously or for medical reasons. Preterm birth occurs in about 10% of all births in the
U. S. with healthcare costs of $26 billion based on the most recent estimate from 2006
("Preterm Birth: Causes, Consequences, and Prevention," 2006). Preterm birth rates have
risen in recent years in the U. S. following a nearly decade of steady decline (J. A. Martin
& Osterman, 2018). Immediate health issues that are more common among infants born
premature include respiratory issues, thermoregulation, feeding difficulties, jaundice and
sepsis that may require initial admission to intensive care as well as increase risk of
rehospitalizations (Saigal & Doyle, 2008). An inverse relationship between length of
gestation and infant morbidity and mortality exists. These risks may persist throughout life
for those born premature. Current evidence supports links between being born prematurely
and increased risk of asthma and respiratory disorders, obstructive sleep apnea,
hypertension, learning difficulties, mental health and behavioral disorders, cardiovascular
disease, as well as insulin resistance and diabetes that persist throughout childhood,
adolescence and into adulthood (Raju et al., 2017). Women who deliver preterm also have
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increased risk of later cardiovascular disease (Bonamy, Parikh, Cnattingius, Ludvigsson,
& Ingelsson, 2011).
The influence of fruit and vegetable intake on preterm birth is inconclusive.
Participants had 18% lower odds of preterm birth when they consumed certain dried fruits
and onion type vegetables in one study (Myhre et al., 2013). In addition, consuming at least
five servings per day of fruits and vegetables less than once a week predicted 31% higher
risk of preterm birth (Smith et al., 2015). Conversely, other studies do not support this
association (Soto et al., 2015; J. Wang et al., 2017).
The immune system is charged with recognition of host or foreign substances and
responding to rid the body of foreign substances, such as viruses or bacteria. Certain types
of lymphocytes called T helper cells (Th cells) produce signaling molecules that either
increase or decrease the body’s response to invasion. There are two primary types of cells
that predominate Th-1 and Th-2. Type Th-1 cells are primarily responsible for intracellular
immunity and produce pro-inflammatory substances such as Interleukin 1(IL-1), interferon
gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α). Type Th-2 is responsible for
extracellular immunity and produce more anti-inflammatory substances such as IL 4, IL5, IL-6 and IL-10. These signaling molecules are numerous and complex so for the
purposes of this paper the term cytokine will be used to refer to them. During pregnancy
the body must protect the foreign fetus from attack by the immune system, with primarily
Th-2 associated immunity.
Recent studies have examined the link between dietary intake of fruits and
vegetables and inflammatory markers. Two recent reviews highlighted the ability of diets
high in fruit and vegetable intake on the expression of markers of inflammation
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(Barbaresko et al., 2013; Wu & Schauss, 2012). The reviewed studies supported that an
inverse relationship exists between pro-inflammatory biomarkers and fruit and vegetable
intake. While a “Western” type diet that is meat based has a positive relationship with
inflammation state (Barbaresko et al., 2013).
Purpose and Specific Aims
This purpose of this study is to examine the relationships among maternal dietary
intake of fruits and vegetables, trimester specific cytokine expression in early and midpregnancy, and birth outcomes. The specific aims are:
Aim 1: To determine whether fruit and/or vegetable intake during early and midpregnancy predicted first or second trimester specific cytokine expression,
controlling for sociodemographic and clinical characteristics.
Aim 2: To determine whether fruit and vegetable intake during early and midpregnancy predicted preterm birth or gestational hypertension, controlling for
sociodemographic and clinical risk factors.
Methods
The data for this secondary analysis are from a multi-center prospective trial of
women with a healthy singleton gestation (K. Ashford et al., 2018). The purpose of the
parent study was to evaluate the differences in maternal trimester specific serum and
cervicovaginal cytokine expression between women who delivered at term and those who
had preterm births. Data were collected during all three trimesters of pregnancy and
postpartum. Only first trimester (8-13 weeks) and second trimester (18-23 weeks) cytokine
and dietary data were used for this study since inflammatory state changes closer to
delivery (K. B. Ashford et al., 2018; Bowen, Chamley, Keelan, et al., 2002).
Sociodemographic characteristics, clinical data, and biologic specimens were collected
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during prenatal visits during the trimesters specified. Clinical and delivery data were
obtained from the medical record.
Sample/setting
In the parent study, women were enrolled from three prenatal clinics in northern,
central and western Kentucky from 2009-2013. Pregnant women 18 years or older with
singleton gestation were included. Exclusion criteria included: pre-existing diabetes,
autoimmune disease, heart disease, current illicit drug use, HIV, and bacterial vaginosis or
sexually transmitted infection Women with complete first trimester data for serum
cytokines, dietary survey data, age, race and birth outcome were retained for the current
study (N=180).
Measures
Sociodemographic and Clinical Characteristics
Participants reported sociodemographic variables that included age, race, income,
marital status and education. Maternal health behaviors of interest included maternal
smoking status, pre-pregnant weight, BMI and gestational weight gain. Weight and height
were obtained from the medical record and used to calculate BMI. Pre-pregnant weight
was by self-report when available, first recorded weight during pregnancy was used instead
if this was not available. Last recorded maternal weight was obtained from medical record.
Maternal smoking status was determined by first trimester urine cotinine level. Maternal
risk factors were included if they could affect any of the birth outcomes of interest or
inflammation. History of a prior preterm birth was determined via self-report.
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Birth outcomes
Preterm birth was defined as gestational age at delivery of less than 37 completed
weeks gestation and was obtained from the medical record. Hypertensive disorders of
pregnancy with available data for this study included pregnancy induced gestational
hypertension and preeclampsia, but due to insufficient cases preeclampsia was not
included. Gestational hypertension diagnosis required at least two high blood pressure
readings (systolic 140 or higher; diastolic 90 or higher) at least four hours apart after 20
weeks gestation, and diagnoses were obtained from the prenatal medical record.
Nutrition
Maternal nutrition variables collected and available for analysis were fruit and
vegetable intake. First and 2nd trimester dietary intake of fruits or vegetables were measured
to evaluate maternal nutrition in early pregnancy. Participants self-reported the number of
servings daily of each food based on standard serving sizes. The number of servings per
day of each food were used in analyses, as well as total fruits and vegetables combined.
Dietary adequacy for fruit and vegetable intake was determined based on U.S. Department
of Agriculture 2015-2020 guidelines (2015). Fruit intake recommendation was met if the
participant consumed at least four servings daily. Vegetable intake was adequate if at least
two and a half servings per day were eaten.
Cytokines
First and second trimester cytokine values were used as they were least likely to be
affected by increasingly pro-inflammatory state that occurs closer to delivery.
Inflammation was measured through inflammatory cytokines present in maternal serum
and cervicovaginal secretions. Specimens were collected from both maternal serum and
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cervicovaginal secretions. Maternal clotted blood specimens were centrifuged for 10
minutes and the serum divide into aliquots to be stored at -80°C until analysis. Samples of
cervicovaginal fluid were obtained using an Aware Messenger (Calypte) swab by sweeping
the cervix for 30 seconds, then sweeping the vaginal vault/posterior fornix 360 degrees
with removal. The swab was placed in the proprietary container, pressed against the inner
wall to ensure maximum fluid seepage into the buffer fluid and the cap secured. All samples
were immediately refrigerated and transported to the laboratory within six hours. They
were stored at -20°C at least 24 hours. The samples were thawed for processing and then
centrifuged, split into aliquots and stored at -80°C. A multiplex Beadlyte assay
(MPXHCYTO-60K-06) was used to measure IL-1α, IL-1β, IL-6, Il-8, Il-10 and TNF-α on
a Luminex IS-100 (Austin, TX) according to manufacturer’s recommendations. Singleplex
assays were used for CRP (Millipore, Billerica, MA) and MMP-8 (R&D Systems,
Minneapolis, MN). All cytokine data were generated using Milliplex Analyst
Software. Log transformations were used on raw cytokine values as the latter are not
normally distributed.
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Health behaviors and Indicators
Maternal smoking status was determined based on first trimester urine cotinine
using the NicAlert® urine assay. The test strip was submerged for 20 seconds in 20-30 ml
of urine. The measurement was obtained after development and result recorded. Values
range from 0-6, with a level of 3 or more used to identify smokers. Prepregnant weight was
used to determine body mass index. Either first recorded maternal weight or patient selfreported pre-pregnant weight was used for pre-pregnant weight. Gestational weight gain
was calculated from as the difference between pre-pregnant weight and last recorded
weight prior to delivery. Body mass index was calculated using the Centers for Disease
Control and Prevention (CDC) formula as weight in kilograms divided by the square of
height in meters. Weight status based on BMI was characterized using the CDC definitions
for underweight, normal weight, overweight and obese women.
Procedure
Approval for the original study was obtained from Institutional Review Board at
each study site. After recruitment and informed consent, the participants completed
questionnaires at their prenatal clinic. Survey data was obtained using Survey Monkey on
I-Pads or on a paper survey, if requested. This was done during regular prenatal visits. The
data was de-identified prior to entry into the secure database. A research nurse reviewed
data entry from paper surveys for accuracy and completeness. When possible, missing data
were entered using information from the medical record. Specimen collection for cytokine
analysis was performed at each prenatal visit.
Data Analysis
Descriptive analysis, including frequency distributions and means and standard
deviations, was used to summarize sociodemographic variables. Prior to analysis, all
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cytokine values were natural log transformed to adjust for lack of normal distribution in
the unadjusted values. Geometric means and standard deviations were used to summarize
these outcomes at each trimester. Specific Aim 1 was tested using linear regression to
evaluate whether first and second trimester intake of fruits and vegetables predicted early
and mid-pregnancy cytokine expression, controlling for personal characteristics. Aim 2
was tested using linear regression to evaluate whether meeting dietary recommendations
for fruit and or vegetable intake during pregnancy predict birth outcome. Aim 2 also
required use of logistic regression to evaluate whether number of servings of fruits and
vegetables predict adverse pregnancy outcome. Variance inflation factors did not exceed
1.6 for any of the included variables, suggesting multicollinearity did not distort regression
estimates. Data analysis was conducted using SPSS 24; an alpha level of .05 was used for
inferential testing.
Results
Participant characteristics
The mean age of the 180 participants was 27.0 years (SD=5.4). The majority had
less than $50,000 per year household income (52.8%), completed at least high school
(90.6%), were white (81.7%) and were non-smokers (79.4%). Most were married or
cohabitating (81.1%) and were pregnant for the first time (64.1%). More than half were
overweight or obese prior to pregnancy (52.9%). More than half gained in excess of
Institute of Medicine recommendations during pregnancy (55.7%). The incidence of
preterm birth was 16.7%in this sample, with 8.9% developing gestational hypertension,
and 4.2% with preeclampsia (Table 4.1).
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Table 4.1 Sociodemographic and clinical characteristics of sample (N=180)
Characteristic
Mean (+ SD) or n (%)
Age
27.01 (±5.39)
Education:
< High school
17 (9.4%)
At least high school
163 (90.6%)
Total household income:
<$25,000/year
53 (30.1%)
$25,000-49,999/year
40 (22.7%)
$50,000 or more/year
83 (47.2%)
Race:
White
147 (81.7%)
Non-white
40 (18.3%)
Marital status:
Single
16 (8.9%)
Dating
15 (8.3%)
Living with partner
33 (18.3%)
Married
113 (62.8%)
Separated
3 (1.7%)
Smoking status:
Smoker
37 (20.6%)
Nonsmoker
143 (79.4%)
Gravida:
1
107 (64.1%)
2
21 (12.6%)
3
23 (13.6%)
4 or more
16 (9.6%)
First trimester intake:
Fruit servings/day
2.4±1.2
Vegetable servings/day
2.3±1.2
Second trimester intake:
Fruit servings/day
2.5±1.2
Vegetable servings/day
2.4±1.1
Intake met:
First trimester fruit
32 (17.8%)
First trimester vegetable
5 (2.8%)
Second trimester fruit
27 (17.6%)
Second trimester vegetable
72 (46.8%)
Pre-pregnancy BMI:
Underweight
1 (0.6%)
Normal weight
83 (46.6%)
Overweight
51 (28.7%)
Obese
43 (24.2%)
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Table 4.1 (Continued) Sociodemographic and clinical characteristics of sample (N=180)
Characteristic
Mean (+ SD) or n (%)
Gestational weight gain:
Less than recommended
30 (18%)
Adequate
44 (26.3%)
More than recommended
93 (55.7%)
Preterm birth
30 (16.7%)
Hypertensive disorders:
22 (13.1%)
Gestational hypertension
15 (8.9%)
Preeclampsia
7 (4.2%)
Frequency and percent (%) were used for categorical values, mean and standard deviation
(SD) for continuous variables.
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For most participants, dietary intake was below recommended amounts for fruits
and vegetables in both first and second trimester. Mean intake was below 2.5 servings daily
(SD≤1.2) for both fruits and vegetables during both first and second trimester. First
trimester fruit intake recommendations were met by 17.8% of participants, while only 2.8%
consumed the recommended amounts of vegetables. Second trimester intake of fruits was
similar with 17.6% reporting adequate intake. Vegetable intake in the second trimester was
adequate for nearly half of participants (46.8%).
The geometric means and standard deviations for serum and cervicovaginal
cytokines are shown in Table 4.2. The mean values were generally stable from first to
second trimester as expected earlier in pregnancy. Serum values were smaller than
cervicovaginal for IL-1α. IL-1β, IL-6 and IL-8 while the reverse is true for IL-10, CRP,
MMP-8 and TNF-α.
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Table 4.2 Geometric means and standard deviations of first and second trimester
cytokines (pg/mL)
Cytokines
Serum
First trimester
Second trimester
IL-1α
1.70 (6.81)
1.55 (6.33)
IL-1β
0.98 (5.87)
0.94 (5.98)
IL-6
2.31 (5.07)
2.38 (5.51)
IL-8
6.09 (2.89)
5.65 (2.95)
IL-10
7.39 (4.24)
8.40 (4.00)
CRP
32.49 (2.97)
35.65 (3.00)
MMP-8
12793.60 (2.76)
15875.00 (2.61)
TNF-α
6.13 (3.45)
7.20 (3.40)
Cervicovaginal
First trimester
Second trimester
IL-1α
500.95 (3.78)
650.67 (4.71)
IL-1β
5.61 (9.56)
6.76 (9.42)
IL-6
3.46 (5.06)
3.73 (4.71)
IL-8
1544.88 (3.81)
1756.36 (5.92)
IL-10
0.60 (2.56)
1.10 (3.46)
CRP
3.88 (14.13)
2.60 (13.11)
MMP-8
76596.00 (4.78)
99927.48 (5.89)
TNF-α
0.87 (3.06)
0.78 (2.94)

Regression analyses
Predictors of Cytokines
Multiple linear regression was used for these analyses while controlling for four
variables known to affect inflammation: smoking status, age, race and obesity. Meeting
daily recommendations for vegetable intake for first trimester predicted higher first
trimester log-transformed serum CRP (β= .20, p=.011), IL-1α (β=.24, p=.003), IL-6
(b=.20, p=.014), and TNFα (b=.19, p=.021), and lower log-transformed cervicovaginal IL6 (b=-.24, p=.006). Meeting recommended fruit intake in the first trimester was associated
with higher log-transformed serum IL-1β (b=.16, p=.045) and lower log-transformed
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cervicovaginal IL-1α (b=-.24, p=.006) (Table 4.3). The number of fruit or vegetable
servings did not predict trimester specific cytokine expression, nor did any of the second
trimester intakes.
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Table 4.3 Significant multiple regression models predicting cytokine levels using demographic and personal variables (N=180)
Cytokine Source
Independent
Dependent variables
Variables
lnIL-1α
sβ (p value)
.14 (.073)

lnIL-1β
sβ (p value)
.10 (.213)

lnIL-6
sβ (p value)
.12 (.122)

lnTNF-α
sβ (p value)
.10 (.175)

Age

First trimester

Pre-Pregnant obesity

.21 (.005)

-.02 (.772)

.06 (.452)

.11 (.142)

-.02 (.842)

White Race

-.09 (.228)

.13 (.086)

.10 (.179)

.07 (.382)

.16 (.035)

Smoking

.16 (.029)

-.08 (.263)

-.15 (.058)

-.12 (.121)

-.02 (.786)

Fruit intake met

-.02 (.353)

-.14 (.076)

.16 (.045)

-.11 (.155)

-.15 (.055)

Vegetable intake met

.20 (.011)

.24 (.003)

.11 (.169)

.20 (.014)

.19 (.021)

Model R2 (p-value)

.13 (.001)

.11 (.003)

.08 (.030)

.09 (.018)

.08 (.020)
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Serum:

lnCRP
sβ (p value)
.06 (.442)

Cervicovaginal fluid:

Age

-.14 (.095)

-.19 (.021)

-.26 (.003)

First trimester

Pre-pregnant obesity

.04 (.627)

-.06 (.481)

-.01 (.881)

White Race

.03 (.755)

.18 (.026)

.07 (.372)

Smoking

.09 (.255)

-.01 (.955)

.07 (.432)

Fruit intake met

-.24 (.006)

-.07 (.429)

-.04 (.611)

Vegetable intake met

.13 (.152)

-.24 (.006)

-.11 (.224)

Model R2 (p value)

.09 (.031)

.12 (.005)

.08 (.046)

Predictors of Birth Outcomes
Logistic regression was used to assess these relationships while controlling for
known risks or predictors of each outcome such as age, race, and smoking status. Eating
more vegetable servings in the first trimester predicted lower odds of PTB (OR=.44;
p=.007). Higher vegetable intake in the second trimester predicted higher odds of
gestational hypertension (OR 2.19, p=.030). Prior history of preterm birth (n=47) is a
known predictor of preterm birth and was included in all models predicting preterm birth.
The adequacy of gestational weight gain based on Institute of Medicine recommendations
was also a significant predictor of preterm birth for both first trimester models, as well as
the model using the met category for fruit or vegetable intake (p<.05 for all). Fruit intake
was not a significant predictor of PTB in either trimester of interest. (Table 4.4).
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Table 4.4 Regression models and corresponding odds ratios for birth outcomes (N=180)
First trimester
Second trimester
Birth Outcome
Preterm Birth
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Gestational Hypertension

Independent variables

Intake Met
# servings
Intake Met
# servings
OR (p value) OR (p value) OR (p value) OR (p value)

Age

.97(.517)

.98(.660)

-.96(.411)

.95(.378)

White Race

1.29(.671)

.914(.884)

.48(.306)

.52(.351)

Smoking

.80(.697)

1.17(.788)

1.03(.962)

.95(.934)

History of PTB

3.74(.011)

5.84(.002)

5.10(.006)

5.90(.004)

IOM weight gain

.46(.011)

.44(.007)

.51(.048)

.53(.068)

Fruit intake

.74(.683)

1.15(.538)

1.29(.758)

.88(.697)

Vegetable intake

.00(.999)

-.830(.007)

.43(.159)

.59(.123)

Model R2 (p value)

.21(.004)

.29(<.001)

.23(.005)

.27(.001)

Age

.95(.437)

.95(.419)

.96(.524)

.98(.727)

White Race

.00(.998)

.00(.998)

.00(.998)

.00(.998)

Smoking

.40(.413)

.36(.363)

.46(.492)

.47(.513)

IOM weight gain

6.40(.061)

6.19(.064)

6.43(.064)

1.73(.087)

Fruit Intake

1.18(.852)

1.08(.978)

1.14(.875)

.69(.306)

Vegetable Intake

1.27(.864)

1.18(.536)

2.67(.163)

2.19(.030)

Model R2(p value)

.20(.024)

.21(.020)

.23(.018)

.27(.007)
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Discussion
Consistent with published data, only small numbers of pregnant women in this
study met recommended fruit and vegetable intakes (17.8% and 2.8% respectively in first
trimester). In 2015, 10.7% of adults in Kentucky met recommended fruit intake, while only
7% consumed enough vegetables (Lee-Kwan et al., 2017).
Maternal serum and cervicovaginal levels of inflammatory cytokines was affected
by maternal intake of vegetables, and to a lesser extent fruit. Vegetable intake of at least
2.5 servings per day had a positive relationship with proinflammatory serum CRP, IL-1α,
IL-6, and TNF-α in this study. Fruit intake increased serum inflammatory IL-1β and
decreased cervicovaginal IL-1α. There are no published studies examining the impact of
fruit and vegetable intake on inflammation among those with healthy pregnancy or
including cervicovaginal cytokines. The current study findings contrast with prior studies
using fetal membrane and myometrial explants which expressed lower concentrations of
inflammatory cytokines TNF-α, IL-1β, and IL-6 when exposed to a citrus extract
(Morwood & Lappas, 2014). Inflammatory status among women with gestational diabetes
was not affected by fruit or vegetable intake (Asemi, Samimi, Tabassi, Sabihi, &
Esmaillzadeh, 2013). Among overweight women, a diet high in fruits and vegetables did
lower expression of IL-6 and IL-1β according to Yeon, Kim, and Sung (2012a). A recent
published review and meta-analysis also contrasted with my findings with fruit or
vegetable intake promoting lower serum CRP and TNF-α levels in adults, but it did not
include pregnant women (Hosseini et al., 2018). Possible explanations for contradictory
findings could be the type of fruit or vegetable ingested. Some fruits and vegetables, such
as berries and dark green leafy vegetables, contain more bioactive compounds called
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phytochemicals which provide more anti-inflammatory benefits (Yu-Jie et al., 2015).
Intakes of known proinflammatory foods such as of sugar, processed foods and red meat
characteristic of “Western” diets promote inflammation (Barbaresko et al., 2013) and could
have affected cytokine secretion as well. During pregnancy, women are instructed to limit
fish consumption to 12 ounces weekly due to concerns of methylmercury contamination
(Gynecologists, 2015). In 2016 Americans consumed an average of 2.7 ounces per week
of fish, which is one-third the recommended amount (Kantor, 2016). Fish and shellfish are
high in anti-inflammatory omega-3 fatty acids. The type of fruits and vegetables consumed,
and other dietary intake is unknown in this population and could also account for the
differences in findings among pregnant women.
Dietary intake of vegetables during the first trimester of pregnancy resulted in 56%
lower risk of PTB for every serving of vegetables controlling for history of PTB as well as
other known risks factors. Prior findings supported the ability of some vegetables and dried
fruit to reduce risk of preterm birth (Myhre et al., 2013), while infrequent consumption of
fruits and vegetables increased the risk (Smith et al., 2015). Dietary patterns that emphasize
intake of fruits and vegetables reduce risk of preterm birth, while those that emphasize
meats and fatty foods promote increased risk of preterm birth overall (Chia et al., 2016;
Englund-Ogge et al., 2014; C. L. Martin, Sotres-Alvarez, & Siega-Riz, 2015; Mikkelsen et
al., 2008; Rasmussen, Maslova, Halldorsson, & Olsen, 2014).
Eating more vegetables in the second trimester predicted higher risk of gestational
hypertension in this study (OR 2.09, p=.039). Fruit intake did not affect risk of gestational
hypertension. These findings contrast with other studies that reported lower risk of
preeclampsia or gestational hypertension with higher intakes of plant based foods
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(Brantsaeter et al., 2007; Endeshaw et al., 2015; Timmermans et al., 2011; Torjusen et al.,
2014; Vieira et al., 2017). Again, the type of vegetables were unknown for this study and
could have affected findings.
In this study, mothers with inadequate gestational weight gain were more likely to
deliver preterm than those with adequate or excess gains. This is consistent with prior
findings that inadequate gains increase the risk of delivering preterm, whereas excess gains
was associated with lower risk of preterm birth (Enomoto et al., 2016; N. Li et al., 2013).
Both preterm birth and hypertensive disorders of pregnancy have an inflammatory
component (Aggarwal et al., 2019; Harmon et al., 2016; Harper et al., 2013; Lyon et al.,
2010). Multiple systematic reviews and meta analyses support an inverse relationship with
diets high in fruit or vegetable content and markers of inflammation in both health and
disease states as well as a positive relationship between diets high in meats and processed
foods (Barbaresko et al., 2013; Casas et al., 2014; Griffiths et al., 2016; Hosseini et al.,
2018; Yeon et al., 2012a). Low intake of fruits and vegetables among Kentuckians may
explain the increased incidence of adverse gestational outcomes. The “Western” diet
consumed by many Americans is high in red meat, sugars and processed foods, and low in
fruits, vegetables and whole grains which may also contribute to adverse gestational
outcomes due to a pro-inflammatory diet. Though obesity and gestational weight gain were
not related to adverse outcomes in this sample, they are linked to adverse gestational
outcomes overall. According to recent statistics, two out of every three women is
overweight or obese in the United States (Diseases, 2017). The balance between pro- and
anti-inflammatory mediators essential to healthy pregnancy may be altered due to obesity
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state as well as dietary factors and result in adverse gestational outcomes such as preterm
birth and hypertensive disorders of pregnancy.
Strengths
This study has several strengths. It presents several firsts for this topic. It is
the first to evaluate the effect of fruit or vegetable intake on markers of inflammation. It is
also the first study to use cytokine data from multiple trimesters in relation to outcomes.
Finally, it is the first study to evaluate the impact of diet on cervicovaginal cytokines. The
relationship between vegetable intake in the first trimester and lower risk of preterm birth
was a novel finding, as was the second trimester intake of vegetables and higher gestational
hypertension risk.
Limitations
Limitations for this study exist and include the use of secondary data for analysis,
which constrained availability of all data relevant to research goals. Given the 3-month
lookback window, the dietary data may have been inaccurate due to incomplete
recollection, and report of fruit and vegetable consumption may have been inflated due to
social desirability of higher intake. Another limitation is the relatively small sample size
and limited instances of some adverse gestational outcomes. Finally, the availability of
only fruit and vegetable in general prevented analysis of the quality of the fruits and
vegetables consumed, as all are not equal in nutritional or anti-inflammatory value.
Conclusions
In conclusion, maternal inflammatory markers are related to fruit and vegetable
intake and birth outcomes. These findings indicate the need for further research to
investigate the impact of fruits and vegetables alone and in the context of overall dietary
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intake on both inflammatory state and birth outcomes. Longitudinal studies that include
larger, more representative samples are needed to either confirm or refute these promising
findings. In addition, including more of the variables suggested by the food environment
and birth outcomes model such as overall diet, exercise and more complete risk factors
would provide a more comprehensive view how maternal diet is impacted by environment,
as well as how diet affects biological factors and birth outcomes.

Copyright © Lori Ogden 2019
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CHAPTER FIVE: Discussion and Conclusions
The overall purpose of this dissertation was to examine relationships between
maternal nutrition during pregnancy, maternal inflammatory state during pregnancy and
adverse perinatal outcomes. Three chapters were included with the individual purposes of:
1) to review and evaluate the current evidence on the relationship between maternal omega3 fatty acid intake and inflammation in pregnancy; 2) to evaluate the current state of the
science on the impact of maternal dietary consumption of fruits and vegetables on the
incidence of preterm birth, gestational diabetes, preeclampsia, small for gestational age,
gestational weight gain and measures of inflammation or oxidative stress in pregnancy;
and 3) to examine the relationships between maternal intake of fruits and vegetables,
trimester specific cytokine expression in early and mid-pregnancy and birth outcomes.
Synthesis of Findings and Implications
The first study was a critical review of literature examining the impact of maternal
intake of omega-3 fatty acids in pregnancy on inflammation in pregnancy. Seven
randomized controlled trials published between 2008-2016 met inclusion criteria and were
included in the full review. Biomarkers of inflammation in both maternal and fetal tissues
were affected by supplementation in five of seven studies. Maternal serum CRP decreased
over time in those receiving the supplement, while this pro-inflammatory cytokine
increased over time for those who did not receive treatment. Both IL-1 and IFN-γ were
lower at delivery for those treated. Maternal adipose tissue levels of IL-6, IL-8 and TNF-α
were lower in those supplemented as well. Both cord and placental levels of several
cytokines were lower in those who were supplemented with omega-3 fatty acids.
The available research supports the ability of omega-3 to affect inflammation in
pregnancy. In addition, no adverse events were reported in any of the included studies.
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However, the optimal time and duration of administration, as well as dosage were less
clear. The American diet is deficient in omega-3 and contains excessive amounts of omega6 fats promoting less than optimal ratios and promoting inflammation. Increasing intake of
omega-3 via food or supplement helps balance this ratio. Americans consume only onethird the recommended amount of fish and shellfish (Kantor, 2016). In addition, pregnant
women are limited or restricted in seafood intake due to worries about mercury
contamination resulting in a diet woefully lacking in omega-3 fatty acids. This author feels
there is enough evidence to support inclusion of omega-3 supplements in pregnancy in
order to promote improved omega-6 to omega-6 ratios and reduce inflammation.
The second study was also a review of recent literature evaluating the impact of
maternal fruit and vegetable consumption on adverse pregnancy outcomes. Nineteen
studies published between 2004-2017 met inclusion criteria and were included in the
review. Higher fruit and vegetable intake in pregnancy reduced the risk of preeclampsia
and small for gestational age. The results were inconclusive for preterm birth and
gestational diabetes. Maternal fruit and vegetable intake did not affect gestational weight
gain. There were no publications evaluating the effect of maternal fruit and vegetable
intake on inflammation or oxidative stress markers in pregnancy.
The significant finding of this review was the overall lack of available evidence on
the impact of maternal fruit and vegetable intake on inflammation and birth outcomes.
However, promoting improved intakes of fruits and vegetables to meet requirements is
important as many Americans do not meet recommended intakes for these key foods (LeeKwan et al., 2017). Since the evidence that exists does support reduced risk of some adverse
outcomes, counseling during antenatal visits should be provided throughout pregnancy.
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The third study examined the relationships between maternal fruit and vegetable
intake in the first two trimesters of pregnancy on cytokine expression during these
trimesters and the risk for preterm birth and gestational hypertension. The specific aims
were: 1) to examine whether fruit and/or vegetable intake during early and mid-pregnancy
predict first or second trimester specific cytokine expression, controlling for
sociodemographic and clinical characteristics; and 2) to assess whether fruit and vegetable
intake during early and mid-pregnancy predicts preterm birth or gestational hypertension,
controlling for sociodemographic and clinical risk factors. A secondary analysis of data
was conducted and included 181 healthy women with singleton gestation and complete
first trimester sociodemographic, cytokine and birth outcome data. First and second
trimester serum and cervicovaginal cytokine data was used as the inflammatory state
changes drastically closer to term.
Meeting recommended two and a half servings per day of vegetables in the first
trimester predicted higher first trimester serum CRP, IL-6 and TNF-α, and lower first
trimester cervicovaginal IL-6. Meeting recommended four servings per day of fruit in the
first trimester predicted higher first trimester serum IL-1β and lower first trimester
cervicovaginal IL-1α. There were no second trimester associations between intake and
cytokines. First trimester number of vegetable servings reduced the odds of delivering
preterm by 54% per serving. Second trimester vegetable intake increased risk of gestational
hypertension by more than two-fold per serving.
There is limited research examining the impact of fruit and vegetable intake on
inflammation and birth outcomes. This is the first study to examine the impact of fruit or
vegetable intake on maternal serum or cervicovaginal cytokine expression in pregnancy

83

overall. Findings from other studies on adults overall support lower cytokine expression
with higher fruit and vegetable intake (Hosseini et al., 2018; Yeon et al., 2012a). Prior
studies reported conflicting results on the impact of a diet high in fruits and vegetables on
preterm birth. Some types of fruits and vegetables did reduce risk in one study (Myhre et
al., 2013), while others did not report an effect (Soto et al., 2015; J. Wang et al., 2017).
One study reported an increased risk of preterm birth for those who ate fruits and
vegetables infrequently (Smith et al., 2015). However, these results are similar to prior
findings that support reduced risk of hypertensive disorders of pregnancy from a diet high
in plant based foods (Brantsaeter et al., 2009; Endeshaw et al., 2015; Timmermans et al.,
2011; Vieira et al., 2017).
These findings provide evidence that dietary intake of omega-3 fatty acids and
fruits and vegetables affects inflammation and some adverse birth outcomes, however
future research is needed. Further study should include randomized controlled trials to
determine the optimal dosage of omega-3 fatty acids DHA and EPA that promote optimal
inflammatory balance during pregnancy. Additional longitudinal studies with larger
sample sizes are needed to add the limited body of evidence on the effects of fruit and
vegetable intake during pregnancy on gestational outcomes and inflammatory state during
pregnancy. Future research should include the use of a framework to guide planning,
design, and implementation in order to conduct studies that are comparable in design and
allow generalizability of findings.
In addition to research, the findings of this dissertation support the need for
evidence based clinical practice changes. Implications for practice include through
evaluation of the maternal diet and encouraging optimal intakes based on current available
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evidence, as many are at risk of inadequate dietary intakes of fruits, vegetables and omega3 rich foods. Fish intake twice weekly is currently recommended and should be
encouraged, specifically fish high in n-3 such as salmon. At least four servings daily of
fruit and two and a half servings daily of vegetables should also be stressed to expectant
mothers. Healthy diet during pregnancy may affect inflammation as well as reduce risk of
preterm birth and gestational hypertension and should be incorporated into routine
antenatal care and counseling.
In conclusion, this dissertation adds to the current science through critical
evaluation of existing literature and research. The current evidence supports the positive
impact of omega-3 fatty acid on inflammation in pregnancy. The evidence also supports a
positive impact on both preeclampsia and optimal fetal growth. The research findings
provide support for fruit and vegetable intakes to reduce risk of preterm birth and
gestational hypertension, as well as affect the inflammatory state during pregnancy.
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APPENDIX A: Newcastle - Ottawa Quality Assessment Scale Case Control Studies
Note: A study can be awarded a maximum of one star for each numbered item within the
Selection and Exposure categories. A maximum of two stars can be given for
Comparability.
Selection (maximum 4 points)
1) Is the case definition adequate?
a) yes, with independent validation*
b) yes (record linkage or based on self-reports)
c) no description
2) Representativeness of the cases
a) consecutive or obviously representative series of cases*
b) potential for selection biases or not stated
3) Selection of Controls
a) community controls*
b) hospital controls
c) no description
4) Definition of Controls
a) no history of disease (endpoint)*
b) no description of source
Comparability (maximum 2 points)
1) Comparability of cases and controls on the basis of the design or analysis
a) study controls for _______________ (Select the most important factor) *
b) study controls for any additional factor*
Exposure (maximum 3 points)
1) Ascertainment of exposure
a) secure record (e.g. surgical records) *
b) structured interview where blind to case/control status*
c) interview not blinded to case/control status
d) written self-report or medical record only
e) no description
2) Same method of ascertainment for cases and controls
a) yes*
b) no
3) Non-Response rate
a) same rate for both groups*
b) non-respondents described
c) rate different and no designation
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APPENDIX B: Newcastle - Ottawa Quality Assessment Scale Cohort Studies
Note: A study can be awarded a maximum of one star for each numbered item within the
Selection and Outcome categories. A maximum of two stars can be given for Comparability
Selection (maximum 4 points)
1) Representativeness of the exposed cohort
a) truly representative of the average _______________ (describe) in the community*
b) somewhat representative of the average ____________ in the community*
c) selected group of users e.g. nurses, volunteers
d) no description of the derivation of the cohort
2) Selection of the non-exposed cohort
a) drawn from the same community as the exposed cohort*
b) drawn from a different source
c) no description of the derivation of the non-exposed cohort
3) Ascertainment of exposure
a) secure record (e.g. surgical records) *
b) structured interview*
c) written self-report
d) no description
4) Demonstration that outcome of interest was not present at start of study
a) yes*
b) no
Comparability (maximum 2 points)
1) Comparability of cohorts on the basis of the design or analysis
a) study controls for _____________ (select the most important factor) *
b) study controls for any additional factor*
Outcome (maximum 3 points)
1) Assessment of outcome
a) independent blind assessment*
b) record linkage*
c) self-report
d) no description
2) Was follow-up long enough for outcomes to occur
a) yes (select an adequate follow up period for outcome of interest) *
b) no
3) Adequacy of follow up of cohorts
a) complete follow up - all subjects accounted for*
b) subjects lost to follow up unlikely to introduce bias - small number lost - > ____ % (select an
adequate %) follow up, or description provided of those lost) *
c) follow up rate < ____% (select an adequate %) and no description of those lost
d) no statement
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APPENDIX C: Newcastle-Ottawa Scale Adapted for Cross-Sectional Studies
Selection: (Maximum 5 stars)
1) Representativeness of the sample:
a) Truly representative of the average in the target population. * (all subjects or random
sampling)
b) Somewhat representative of the average in the target population. * (non-random sampling)
c) Selected group of users.
d) No description of the sampling strategy.
2) Sample size:
a) Justified and satisfactory. *
b) Not justified.
3) Non-respondents:
a) Comparability between respondents and non-respondents’ characteristics is established,
and the response rate is satisfactory. *
b) The response rate is unsatisfactory, or the comparability between respondents and nonrespondents is unsatisfactory.
c) No description of the response rate or the characteristics of the responders and the nonresponders.
4) Ascertainment of the exposure (risk factor):
a) Validated measurement tool. **
b) Non-validated measurement tool, but the tool is available or described.*
c) No description of the measurement tool.
Comparability: (Maximum 2 stars)
1) The subjects in different outcome groups are comparable, based on the study design or
analysis. Confounding factors are controlled.
a) The study controls for the most important factor (select one). *
b) The study control for any additional factor. *
Outcome: (Maximum 2 stars)
1) Assessment of the outcome:
a) Independent blind assessment. *
b) Record linkage * OR
c) Self report*.
d) No description.
2) Statistical test:
a) The statistical test used to analyze the data is clearly described and appropriate, and
the measurement of the association is presented, including confidence intervals and the
probability level (p value). *
b) The statistical test is not appropriate, not described or incomplete.
This scale has been adapted from the Newcastle-Ottawa Quality Assessment Scale for cohort
studies to perform a quality assessment of cross-sectional studies for the systematic review, “Are
Healthcare Workers’ Intentions to Vaccinate Related to their Knowledge, Beliefs and Attitudes?
A Systematic Review”.
I have not selected one factor that is the most important for comparability, because the variables
are not the same in each study. Thus, the principal factor should be identified for each study.
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